UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10

 

GENERAL FORM FOR REGISTRATION OF SECURITIES

 

Pursuant to Section 12(b) or (g) of The Securities Exchange Act of 1934

 

YAKUN INTERNATIONAL INVESTMENT AND HOLDING GROUP
(Exact name of registrant as specified in its charter)

 

NEVADA   33-1176182
(State or other jurisdiction of incorporation or organization)   (I.R.S. Employer Identification No.)
     
Suite 1515, 1501 Broadway, New York, NY   10036
(Address of principal executive offices)   (Zip Code)
     
Registrant’s telephone number, including area code   (212) 324-1876

 

Securities to be registered pursuant to Section 12(b) of the Act:

 

Title of each class

to be so registered

 

Name of each exchange on which

each class is to be registered

 

Securities to be registered pursuant to Section 12(g) of the Act: Common Stock, par value $0.001 per share

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer   Accelerated filer
Non-accelerated filer (Do not check if a smaller reporting company) Smaller reporting company
      Emerging Growth Company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.                  ☐

 

 

 

 

 

 

TABLE OF CONTENTS

 

    Page No.
Item 1. Business. 1
Item 1A. Risk Factors. 6
Item 2.   Financial Information. 13
Item 3.   Properties. 17
Item 4. Security Ownership of Certain Beneficial Owners and Management. 17
Item 5.   Directors and Executive Officers. 18
Item 6. Executive Compensation. 19
Item 7.   Certain Relationships and Related Transactions, and Director Independence. 20
Item 8.   Legal Proceedings. 21
Item 9. Market Price of and Dividends on the Company's Common Equity and Related Stockholder Matters. 21
Item 10. Recent Sales of Unregistered Securities. 22
Item 11. Description of Company's Securities to be Registered. 23
Item 12. Indemnification of Directors and Officers. 23
Item 13. Financial Statements and Supplementary Data. 24
Item 14. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure. 24
Item 15. Financial Statements and Exhibits. 24

 

 

 

 

FORWARD LOOKING STATEMENTS

 

This registration statement contains certain "forward looking statements" as defined under the U.S. federal securities laws. Generally, the words "believe," "expect," "intend," "estimate," "anticipate," "project," "will," and similar expressions identify forward looking statements, which generally are not historical in nature. Forward looking statements are subject to certain risks and uncertainties that could cause actual results to materially differ from the Company's historical experience and its current expectations or projections indicated in any forward looking statements. These risks include, but are not limited to, risks associated with beginning a new business, operating risks, risks associated with raising capital, dependence upon management and risks associated with recruiting personnel, our ability to develop our untested water treatment solutions and market acceptance thereof, compliance with environmental and other governmental regulations, competition with existing and future providers of water treatment solutions, as well as the other risks described in Item 1.A hereof and discussed in our future filings with the SEC. You should not place undue reliance on forward looking statements, which speak only as of the date they are made. We undertake no obligation to update or revise any forward looking statements made herein.

 

Also, forward-looking statements represent our estimates and assumptions only as of the date of this registration statement. You should read this registration statement and the documents that we reference and filed as exhibits to this registration statement completely and with the understanding that our actual future results may be materially different from what we expect. Except as required by law, we assume no obligation to update any forward-looking statements publicly, or to update the reasons actual results could differ materially from those anticipated in any forward-looking statements, even if new information becomes available in the future.

 

 

 

 

Use of Certain Defined Terms

 

Except where the context otherwise requires and for the purposes of this report only:

 

 

the “Company,” “PBG, “we,” “us,” and “our” refer to the registrant, Yakun International Investment and Holding Group, a Nevada corporation, and its wholly-owned subsidiary, PBG Water Solutions International, Inc., a Nevada corporation, including its predecessor, PBG Water Solutions International, Inc., a Delaware corporation which merged into the Nevada PBG on October 18, 2017;

   
 

“Exchange Act” refers to the Securities Exchange Act of 1934, as amended;

 

  “PRC,” “China,” and “Chinese,” refer to the People’s Republic of China (excluding Hong Kong and Taiwan); 
   
 

“Securities Act” refers to the Securities Act of 1933, as amended; and

 

 

“US dollars,” “dollars” and “$” refer to the legal currency of the United States.

 

ITEM 1. BUSINESS.

 

On January 15, 2018, the registrant acquired all of the issued and outstanding shares of the capital stock of PBG Water International Solutions, Inc. a Nevada corporation (“PBG”). PBG was organized to explore the market in the United States for wastewater treatment solutions and subsequently expanded its focus to markets outside the United States. On April 3, 2017, PBG entered into a License and Supply Agreement (the “License Agreement”) with Beijing QHY Environment S&T Co. Ltd., a corporation organized under the laws of the People’s Republic of China (the “Licensor”), pursuant to which PBG was granted the exclusive right to 21 patents and related technologies related to wastewater treatment solutions. The principal stockholders of PBG desire to access the US capital markets to obtain funds to initiate operations in the United States and complete such contracts as it may enter.

 

Organizational History

 

We were incorporated in the state of Nevada on October 16, 2007 under the name Rhino Productions, Inc. On September 13, 2011, we consummated a Share Exchange Agreement with the shareholders of Vast Glory Holdings Limited, pursuant to which we acquired 100% of the outstanding capital stock of Vast Glory in exchange for approximately 68% of our issued and outstanding capital stock on a fully-diluted basis. At the time of the acquisition, Vast Glory, through a series of wholly-owned subsidiaries, controlled the operations of and was entitled to receive the pre-tax profits of its variable interest entity, Changchun Decens Foods Co., Ltd. (“Decens Foods”), a PRC company. Thus, as a result of the acquisition of Vast Glory, we acquired the economic benefits of the operations of Decens Foods.

 

Effective December 14, 2011, we changed our corporate name to Yakun International and Investment Group.

 

In July 2014, we filed a Form 15 and elected to cease filing under the Exchange Act. Subsequently, on July 23, 2014, we entered into an agreement with Decens Foods and its shareholders relinquishing our interests in Decens Foods to its shareholders in China. Concurrently, we disposed of our interest in Vast Glory and hence, the entities owned by it. Consequently, as of July 31, 2014, we were once again a corporation with no business and minimal or nominal assets.

 

On January 15, 2018, we acquired all of the issued and outstanding shares of the capital stock of PBG in exchange for 46,839,439 shares of common stock and 19,000 shares of Series A Convertible Preferred Stock (“Series A Preferred Stock”) pursuant to an Exchange Agreement dated as of November 17, 2017 (The “Exchange Agreement”) with the former stockholders of PBG. Each share of Series A Preferred Stock was convertible into 1,000 shares of common stock and were so converted on April 18, 2018. PBG was the successor by merger to PBG Water International Solutions, Inc. a Delaware corporation which had been formed on August 4, 2016.

 

In addition to our acquisition of PBG, in December 2017 we formed QHY Water Solutions International Corp. a Nevada corporation (“QHY”). QHY owns 51% of the capital stock of QHY New Zealand LLC. A Nevada limited liability company, and QHY Oceania S & T Co., Ltd., a New Zealand company.

 

  1  

 

 

As a result of the disposition of Decens Foods, the acquisition of PBG and the formation of the subsidiaries mentioned above, our organizational structure is as follows:

 

 

  2  

 

 

The acquisition of PBG was accounted for as a “reverse merger”, whereby PBG is the continuing entity for financial reporting purposes and was deemed, for accounting purposes, to be the acquirer of our company. Although we legally acquired PBG, in accordance with the applicable accounting guidance for accounting for a reverse merger, PBG’s historical financial statements are now the financial statements of the registrant and the assets and liabilities of Yakun have been brought forward at their historical book value and no goodwill has been recognized.

 

Upon effectiveness of this Registration Statement, we will be subject to all of the reporting obligations required by Section 13(a) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”).

 

Business Overview

 

On April 3, 2017, we entered into a License and Supply Agreement (the “License Agreement”) with Beijing QHY Environment S&T Co. Ltd. and Mr. Mao Xu, pursuant to which we acquired the exclusive right to 21 patents and related technologies for the treatment of wastewater. The License Agreement was amended in certain respects on June 22, 2017. The patents subject to the License as amended include two international patents and 19 Chinese national patents covering a variety of compositions, processes and equipment which can be used to treat wastewater. The agreement grants us the worldwide exclusive right to use the technologies which are the subject of the License for a term extending through June 30, 2037, or, if later, the last to expire of the patents which are the subject of the License. The patents relate to various powders, methodologies and equipment useful in the treatment of wastewater. The License requires that we pay a royalty equal to 1% of our net revenues, as defined in the License, with a one-time fee of $1million to be paid no later than December 31, 2021. Mao Xu, our Chairman of the Board and Chief Executive Officer, who beneficially owns approximately 41.6% of our outstanding common stock owns a majority of the outstanding shares of Beijing QHY Environment S&T Co. Ltd. (the “Beijing QHY”).

 

We intend to recruit personnel in the United States to commence efforts to market solutions for the treatment of wastewater based upon the intellectual property acquired pursuant to the Licensing Agreement. These solutions include stand-alone processing plants designed to be transported, housed and maintained in standard shipping containers and mineral based powders used to treat the subject wastewaters.

 

In addition to licensing certain key technologies from Beijing QHY, we will likely purchase from Beijing QHY any equipment, supplies and other consumables ordered by our clients. The prices at which such items are acquired by us will be determined by negotiation between Beijing QHY and our directors.

 

The systems to be provided by PBG are based upon advanced principles associated with flocculation, coagulation and separation. The main ingredient, Yiyou ion separation purifier, is a natural mineral based powder that under the right conditions breaks the ionic bonds in organic and inorganic matters in wastewater. The substances then re-bond with positive and negative ions in Yiyou, causing the pollutants to cohere initially, into micro particles and, over a short time, into larger particles which fall to the bottom of the processing container allowing the “clean” water to be siphoned off for further treatment depending upon the desired quality of the end product. Because of the speed at which PBG’s systems can cleanse certain wastewater streams, it may be particularly useful in a variety of situations where the goal is not to purify the water to the point where it can be consumed by humans or animals but rather simply eliminate a sufficient quantity of the pollutants to allow the water to be recycled into river or lake or be reused in an industrial process.

 

The PBG systems have been demonstrated to be effective in the treatment of various streams of wastewater and, in PBG’s estimation, can economically be used to treat wastewater in a variety of industries as well as polluted lakes and ponds. A principle advantage of the system is that the processing plant has been designed to be housed in a standard international shipping container, allowing for easy transportation and installation. Systems can be scaled simply by adding more processing containers.

 

  3  

 

 

PBG envisions that its systems can be used in a variety of industries, such as industrial wastewater treatment where the pollutant is chemicals, heavy metals and mining runoff; sewage treatment and the purification of waste ponds typically found on industrial sized poultry, pork and cattle farms; residential wastewater treatment where the pollutants vary and can be combined with industrial wastes and rainwater runoff. Significantly, because of the portability and size of the basic processing plant, PBG’s systems can easily be combined with other common methods of treating wastewaters to enhance their effectiveness and efficiency.

 

PBG intends to offer customers their choice of whether to operate the systems on their own or to contract with PBG for a complete outsourced service. In each case, PBG will participate in the design of the system and the customization of the materials and dosing to be used to most economically treat the pollutants found in the customer’s wastewater. The patents and associated products we licensed from Mr. Mao and Beijing QHY enable us to provide comprehensive wastewater treatment solutions by applying an innovative wastewater treatment technology - Ion-Separation-Exchange Technology, to ensure that various wastewater reach the disposal standard after treatment. The technology is advanced in the sense that:

 

  it not only standalone effectively removes various water contaminants to meet dischargeable standards, but also could be combined with other water treatment technics, such as Biological Reduction, Reverse Osmosis, Permeable Reactive Barriers, etc., to meet the treatment result customers desire;

 

  lower than traditional equipment and additives cost, and better economics;

 

  less reaction time to realize continuous water flow treatment in various scenarios;

 

  mobile equipment units, flexible capacity design and less space occupation;

 

  non-hazardous sludge and no secondary pollution;

 

The Market

 

The demand for clean pollutant free water continues to grow. As the supply of water is limited, the market for technologies designed to recapture contaminated water so that it can be recycled for industrial uses or purified for use as drinking water continues to expand. The processes employed to clean water range from simple gravity ponds to engineered chemical treatments. The global water and wastewater treatment market was approximately $478 billion in 2016 and is expected to grow to nearly $675 billion by 2025. The global market for industrial wastewater treatment was approximately $109 billion in 2016 and is expected to reach $132 billion by 2020.

 

Competition

 

The market for wastewater and industrial wastewater treatment can be divided by industry, the processing method used to treat the wastewater and whether the output is intended to be used for industrial purposes or human and animal consumption. Although there are certain well-known technologies employed across a variety of industries, often a customer requires an engineered solution unique to its needs and a number of technologies are combined to achieve the desired result. Consequently, the sales cycle is often long and tedious requiring one on one meetings at which the provider convinces the prospective customer of the benefits of its system. Given that adoption of a system often requires significant capital expenditures, customers are reluctant to switch to new, unproven systems. As a result, PBG intends to market its systems to entities first seeking to treat their wastewaters and in situations where it believes the portability and scalability of its processing system will prove advantageous.

 

  4  

 

 

There are numerous large, highly sophisticated and well financed engineering firms and other entities engaged in the design of water treatment facilities. Competitors range from those capable of designing, maintaining and operating large municipal water facilities, those dealing with the disposal needs of laboratories, hospitals and other medical facilities and those engaged in recycling water used on farms.

 

Regulation

 

Our existing and planned water operations are subject to extensive federal, state and local laws and regulations, which govern the protection of the environment, health and safety, water allocation rights, and the manner in which we collect, treat, discharge and dispose of wastewater. Our planned operations in other countries will be also subject to regulatory standards and code enforcement, which typically require that our solutions and products meet stringent performance criteria.

 

In the United States, these requirements include the United States Clean Water Act of 1972, which we refer to as the “Clean Water Act”. The Clean Water Act regulates discharges of wastewater treatment facilities into lakes, rivers, streams and groundwater. In addition to requirements applicable to our wastewater collection systems, our operations require discharge permits under the National Pollutant Discharge Elimination System (“NPDES”) permit program established under the Clean Water Act, which must be renewed every five years. Pursuant to the NPDES permit program, the Environmental Protection Agency (“EPA”) and implementing states set maximum discharge limits for wastewater effluents and overflows from wastewater collection systems. Discharges that exceed the limits specified under NPDES permits can lead to the imposition of penalties, and persistent non-compliance could lead to significant penalties and compliance costs. The Comprehensive Environmental Response, Compensation, and Liability Act of 1980 (“CERCLA”), authorizes the EPA, and comparable state laws authorize state environmental authorities, to issue orders and bring enforcement actions to compel responsible parties to investigate and take remedial actions at any site that is determined to present an actual or potential threat to human health or the environment because of an actual or threatened release of one or more hazardous substances. If we enter into operations of utilities that provide water and wastewater services to residential, commercial, industrial, and public, we will be subject to economic regulation by certain state utility commissions or other entities engaged in utility regulation, collectively referred to as Public Utility Commissions (“PUCs”).

 

International standards that will regulate our operation are established by such organizations as the International Code Council (ICC), the International Association of Plumbing and Mechanical Officials (IAPMO), and the national regulatory standards that vary by country. For example, major standards and guidelines in European countries include Kiwa NV (Netherlands), Association Française de Normalisation (France), Swiss Gas and Water Industry Association (Switzerland), Water Regulations Advisory Scheme (UK), etc. New Zealand, a country in which we are in process of establishing businesses, established National Policy Statement for Freshwater Management (Freshwater NPS) in 2014 that provides direction on how local authorities should carry out their responsibilities under the Resource Management Act 1991 for managing fresh water. New Zealand government amended Freshwater NPS in 2017 to a more stringent level of standards for dischargeable wastewater.

 

We may also be required to obtain various environmental permits from regulatory agencies for our operations. Certain of these permits require substantial lead time to obtain and, once obtained, require that certain compliance tasks must be completed on a regular basis in order to maintain such permits.

 

In developing business opportunities, PBG has undertaken various trial wastewater treatment projects with potential customers, and independent certified institutions were engaged to assess the output of each project. In each case, the results met the regulatory standards the potential customer had targeted. The wastewater we ran trials on included the discharge from a lead-zinc mining operation, an industrial sized cattle farm, a paper mill, a polluted urban river, industrial park sewages, and an oil and gas field.

 

  5  

 

 

Employees

 

As of December 31, 2017, the Company had one officer and no employees or financial obligations associated with previous employment agreements. One employee was hired in May 2018. To date, PBG’s original shareholders performed various services for us for no compensation.

 

In developing our water solutions business, we’ve engaged various independent contractors who are not our employees.

 

Our Principal Office

 

Our principal office is located at Suite 1515, 1501 Broadway, New York, New York 10036. The office is provided to us by Pluris Capital Group, an entity affiliated with Roy Teng, one of our directors, as part of a financial advisory agreement pursuant to which we will pay Pluris $30,000 per quarter from June 2018. The agreement has a term of five years but is cancellable by either party on sixty days’ notice. Our telephone number is (212) 324 1876.

 

ITEM 1A. RISK FACTORS.

 

An investment in our common stock involves a high degree of risk. You should carefully consider the following risk factors in addition to other information in this prospectus before purchasing our common stock. The risks and uncertainties described below are those that we currently deem to be material and that we believe are specific to our company, our industry and our stock. In addition to these risks, our business may be subject to risks currently unknown to us. If any of these or other risks actually occurs, our business may be adversely affected, the trading price of our common stock may decline and you may lose all or part of your investment.

 

Risks Related to Our Operations

 

We have not generated any revenues and may not be able to continue to operate as a going concern.

 

We have not generated any revenues and suffered net losses of $207,504 and $12,212 for the years ended December 31, 2017 and 2016, respectively, and at December 31, 2017, we had an accumulated deficit of $219,716. The report of our independent registered public accountants on our financial statements as of and for the year ended December 31, 2017 and 2016 states that these factors raise uncertainty about our ability to continue as a going concern.

 

We require significant funding to commence operations.

 

In order to carry out our intended business plan, we will require significant funding to fund operating expenses prior to generating significant revenues. There is no guarantee that we will be able to raise sufficient capital to implement our plan of operations. The inability to obtain any such funding could materially affect our ability to implement our business plan.

 

We are subject to significant operating risks.

 

Our business is subject to numerous risks associated with a new, low-capitalized company engaged in our business sector. Such risks include, but are not limited to, competition from well-established and well-capitalized companies, risks associated with pricing, volumes and continued demand for wastewater treatment services, regulatory and environmental risks, as well as unanticipated difficulties regarding the marketing and sale of our services. There can be no assurance that we will ever generate sufficient commercial sales or achieve profitability. Should this be the case, our common stock could become worthless and investors in our common stock or other securities could lose their entire investment.

 

  6  

 

 

Risks Related to our Growth

 

We depend on our management, without whose services our business operations could be adversely affected or cease.

 

At this time, our management is wholly responsible for the development and execution of our business plan. If our management should choose to leave us for any reason before we hire additional personnel, our operations could be adversely effected. Even if we are able to find additional personnel, it is uncertain whether we could find qualified management who could develop our business along the lines described herein or would be willing to work for compensation that we could afford.

 

We will need to increase the size of our organization, and may experience difficulties in managing growth.

 

We are a small company with a limited management team, and limited corporate infrastructure. We expect to continue to experience a period of significant expansion in headcount, facilities, infrastructure and overhead to address potential growth and market opportunities and to meet our reporting requirements under the Exchange Act. Future growth will impose significant added capital requirements, as well as added responsibilities on members of management, including the need to identify, recruit, maintain and integrate new personnel. Our future financial performance and our ability to compete effectively will depend, in part, on our ability to manage any future growth effectively.

 

We expect our operating expenses to increase substantially in the future as we attempt to grow our business, and we may need to raise additional funds to meet the demands of growth initiatives.

 

We expect that our operating expenses will increase substantially over the next 12 months as we endeavor to implement growth initiatives, both organically and through acquisitions. As a result, we may need to raise additional funds in the future, and such funds may not be available on commercially reasonable terms, if at all. If we cannot raise funds on acceptable terms, we may not be able to implement our business plan, take advantage of future opportunities, or respond to competitive pressures or unanticipated requirements. This could seriously harm our business, financial condition and results of operations.

 

In order to meet our capital needs, we may be required to make additional borrowings or be required to issue new debt securities in the capital markets. We can provide no assurances that we will be able to access the debt capital markets or do so on favorable terms. If new debt is added to our current debt levels, the related risks we now face could intensify, limiting our ability to refinance existing debt on favorable terms. We will depend primarily on operations to fund our expenses and to pay the principal and interest on our outstanding debt. Our ability to meet our expenses thus depends on our future performance, which will be affected by financial, business, economic, competitive, legislative, regulatory and other factors beyond our control. If we do not have enough money to pay the principal and interest on our outstanding debt, we may be required to refinance all or part of our existing debt, sell assets, borrow additional funds or sell additional equity. If our business does not generate sufficient cash flow from operations or if we are unable to incur indebtedness sufficient to enable us to fund our liquidity needs, we may be unable to plan for or respond to changes in our business that would prevent us from maintaining or increasing our business and cause our operating results and prospects to be affected adversely.

 

  7  

 

 

We may not be able to fully develop the water treatment solutions we are presently targeting.

 

We believe that one of our competitive advantages will be our ability to develop all-inclusive services that offer proprietary and innovative water treatment systems and solutions. The technologies we have licensed and on which we depend have only recently been developed. We have not engaged independent engineers or our own personnel to conduct testing to determine long-term effectiveness of such systems, nor have we deployed these solutions with any customers to determine commercial acceptance. Accordingly, we can offer no assurances as to the effectiveness or commercial viability of our treatment systems.

 

Our proposed water treatment solutions are unproven and may not achieve widespread market acceptance among our prospective customers. If we are unable to sell our water treatment systems, our business will suffer.

 

Our solutions and processes for water treatment will compete with other forms of water treatment technologies that currently are in operation throughout the world. Our water treatment solutions and the systems on which they are based may not achieve widespread market acceptance. Our success with our water treatment solutions will depend on our ability to market our system and services to businesses on terms and conditions acceptable to us and to establish and maintain successful relationships with various water providers and state regulatory agencies.

 

We believe that market acceptance of our system will depend on many factors including:

 

  our current and future relationships with market participants;

 

  the perceived advantages of our system over competing water treatment solutions;

 

  the safety and efficacy of our system;

 

  the availability of alternative water treatment solutions;

 

  the pricing and cost effectiveness of our system;

 

  our ability to access businesses and water providers that may use our system;

 

  the effectiveness of our sales and marketing efforts;

 

  publicity concerning our system and technology or competitive solutions;

 

  timeliness in assembling and installing our system on or near customer sites;
     
  our ability to respond to changes in regulations; and

 

  our ability to provide effective service and maintenance of our systems to our customers’ satisfaction.

 

If our system fails to achieve or maintain market acceptance or if new technologies are introduced by others that are more favorably received than our systems, are more cost effective, or otherwise render our systems obsolete, we may not be able to sell our systems. If we are unable to sell our systems, our business and prospects would suffer.

 

Our operations are subject to extensive environmental laws and regulations. Our operating costs may increase as a result of complying with environmental laws and regulations. We also could incur substantial costs as a result of violations of or liabilities under such laws and regulations.

 

Our existing and planned water operations are subject to extensive federal, state and local laws and regulations, which govern the protection of the environment, health and safety, water allocation rights, and the manner in which we collect, treat, discharge and dispose of wastewater. These requirements include the United States Clean Water Act of 1972, which we refer to as the “Clean Water Act”. We may also be required to obtain various environmental permits from regulatory agencies for our operations. Certain of these permits require substantial lead time to obtain and, once obtained, require that certain compliance tasks must be completed on a regular basis in order to maintain such permits. State regulatory agencies also set conditions and standards for the water and wastewater services we deliver. If we deliver water or wastewater services to our customers that do not comply with regulatory standards, or otherwise violate environmental laws, regulations or permits, or other health and safety and water quality regulations, we could incur substantial fines, penalties or other sanctions or costs or damage to our reputation. In the most serious cases, regulators could force us to discontinue operations. We will incur substantial operating and capital costs on an ongoing basis to comply with environmental laws and regulations and other health and safety and water quality regulations. These laws and regulations, and their enforcement, have tended to become more stringent over time, and new or stricter requirements could increase our costs.

 

  8  

 

 

Although we may seek to recover ongoing compliance costs in our pricing, there can be no guarantee that such pricing may be sustained in the marketplace. We may also incur liabilities under environmental laws and regulations requiring us to investigate and clean up environmental contamination at our properties or at off-site locations where we have disposed of waste or caused adverse environmental impacts. We may also be subject to liability if we improperly handle, transport, process or dispose of contaminated water. The discovery of previously unknown conditions, the improper handling by us of contaminated water or other materials, or the imposition of cleanup obligations in the future, could result in significant costs, and could adversely affect our financial condition, results of operations, cash flow and liquidity. Such remediation losses may not be covered by our insurance policies and may make it difficult for us to secure insurance in the future at acceptable rates. If any remediation losses that are not covered by insurance are excessive, we may be required to significantly curtail our operations.

 

Our business depends on spending for the treatment of wastewater, and this spending may be adversely affected by industry and financial market conditions that are beyond our control.

 

We will depend on our customers’ willingness to make operating and capital expenditures to treat their wastewaters. A belief on the part of our potential customers that their businesses may decline may cause our customers to curtail spending, thereby reducing demand for our services. Industry conditions are influenced by numerous factors over which we have no control.

 

Geopolitical conditions and global economic factors may adversely affect us.

 

Uncertain geopolitical conditions and global economic factors may adversely affect our business. Adverse factors affecting economic conditions worldwide have contributed to a general inconsistency in the world’s economies and may adversely impact our business, resulting in reduced demand for water remediation and supply. The current and ongoing uncertainty of the international economic situation, civil unrest, terrorist activity and military actions may continue to adversely affect global economic conditions. Economic and market conditions could deteriorate as a result of any of the foregoing reasons. We may experience material adverse effects on our business, financial condition, results of operations and cash flows as a consequence of the foregoing factors.

 

Changes in laws and regulations over which we have no control can significantly affect our business and results of operations.

 

Any governmental entity that regulates our operations may enact new legislation or adopt new regulations or policies at any time, and new judicial decisions may change the interpretation of existing legislation or regulations at any time. The individuals who serve as regulators are elected or are political appointees. Therefore, elections which result in a change of political administration or new appointments may also result in changes in the individuals who serve as regulators and the policies of the regulatory agencies that they serve. New laws or regulations, new interpretations of existing laws or regulations, or changes in agency policy, including as a response to shifts in public opinion, or conditions imposed during the regulatory hearing process may affect our business in a number of ways.

 

  9  

 

 

If we do not compete successfully against existing and new competitors, we may lose market share and suffer losses.

 

There are numerous large, highly sophisticated and well financed engineering firms and other entities engaged in the design of water treatment facilities. Competitors range from those capable of designing, maintaining and operating large municipal water facilities, those dealing with the disposal needs of laboratories, hospitals and other medical facilities and those engaged in recycling water used on farms.

 

We believe that our ability to compete depends upon many factors both within and beyond our control. Some of our current and potential competitors may have greater financial, engineering, marketing, and other resources than we have. Certain of our competitors may be able to devote greater resources to marketing and promotional campaigns and devote substantially more resources to system development than us. Increased competition may reduce our market share and require us to increase our marketing and promotional efforts, which could negatively affect our operating margins or force us to incur losses. There can be no assurance that we will be able to compete successfully against current and future competitors, and competitive pressures may have a material adverse effect on our business, prospects, financial condition and results of operations.

 

Risks Related to Ownership of Common Stock and Operation as a Public Company.

 

There is no current trading market for our common stock, and there is no assurance of an established public trading market, which would adversely affect the ability of our investors to sell their shares in the public market.

 

Our common stock is quoted on OTC Pink under the symbol "YIHG"; however; an active trading market for our shares does not exist. We cannot assure you that a regular trading market for our shares of common stock will develop, or that if one develops, that it will be sustained.

 

The market price and trading volume of shares of our common stock may be volatile.

 

If a market develops for our securities, the market price of our common stock could fluctuate significantly for many reasons, including reasons unrelated to our specific performance, such as reports by industry analysts, investor perceptions, or announcements by our competitors regarding their own performance, as well as general economic and industry conditions. For example, to the extent that other large companies within our industry experience declines in their share price, our share price may decline as well. Fluctuations in operating results or the failure of operating results to meet the expectations of public market analysts and investors may negatively impact the price of our securities.

 

Quarterly operating results may fluctuate in the future due to a variety of factors that could negatively affect revenues or expenses in any particular quarter, including vulnerability of our business to a general economic downturn; changes in the laws that affect our products or operations; competition; compensation related expenses; application of accounting standards; and our ability to comply with all necessary regulatory permits and/or licenses to conduct our business. In addition, if the market price of our shares should ever drop significantly, stockholders could institute securities class action lawsuits against us, even though there may be no legal basis for any such lawsuit. A lawsuit against us could cause us to incur substantial costs and could divert the time and attention of our management and other resources.

 

  10  

 

 

Our Chairman of the Board and Chief Executive Officer owns the Licensor and therefore actions taken on behalf the Licensor may not be in the best interests of our stockholders.

 

Mr. Mao Xu, our Chairman of the Board and Chief Executive Officer, who beneficially owns approximately 41.6% of our outstanding shares of common stock, owns the patents we licensed and is a majority of the outstanding shares of the Beijing QHY, and therefore has a conflict of interest in matters affecting the License Agreement, and actions taken on behalf of the Licensor may not be in the best interests of our stockholders.

 

We may suffer a change in control and our business could be significantly harmed if an owner of a significant number of our shares, including our Chairman of the Board and Chief Executive Officer or other directors pledge their shares to secure loans and default in the payment of those loans.

 

If Mao Xu, our Chairman of the Board and Chief Executive Officer, who owns approximately 41.6% of our outstanding shares, or Yu Tao or Roy Teng, our other directors, each of whom owns approximately 20.8% of our outstanding shares, was to pledge his shares to secure the payment of a loan, and then default in the payment of that loan, the default could result in a sale of a substantial number of our common shares resulting in a decrease in the price of our shares and a change in control of our company.

 

If we fail to develop and maintain an effective system of internal controls, we may not be able to accurately report our financial results or prevent fraud, as a result, current and potential stockholders could lose confidence in our financial reports, which could harm our business and the trading price of our common stock.

 

Effective internal controls are necessary for us to provide reliable financial reports and effectively prevent fraud. Section 404 of the Sarbanes-Oxley Act of 2002 requires us to evaluate and report on our internal controls over financial reporting. Compliance with Section 404 requires that we strengthen, assess and test our system of internal controls to provide the basis for our report. The process of strengthening our internal controls and complying with Section 404 is expensive and time consuming, and requires significant management attention. We cannot be certain that the measures we undertake will ensure that we will maintain adequate controls over our financial processes and reporting in the future. Furthermore, if we are able to rapidly grow our business, the internal controls that we will need will become more complex, and significantly more resources will be required to ensure our internal controls remain effective. Failure to implement required controls, or difficulties encountered in their implementation, could harm our operating results or cause us to fail to meet our reporting obligations. If we discover a material weakness in our internal controls, the disclosure of that fact, even if the weakness is quickly remedied, could diminish investors' confidence in our financial statements and harm our stock price. In addition, non-compliance with Section 404 could subject us to a variety of administrative sanctions, including the suspension of trading, ineligibility for listing on the OTC Markets, and the inability of registered broker-dealers to make a market in our common stock, which would further reduce our stock price.

 

We will incur increased costs as a result of operating as a public company, and our management will be required to devote substantial time to compliance efforts.

 

As a public company, we will incur significant legal, accounting and other expenses that we did not incur as a private company. The Sarbanes-Oxley Act and related SEC regulations, have created uncertainty for public companies and significantly increased the costs and risks associated with accessing the public markets and public reporting. For example, on January 30, 2009, the SEC adopted rules requiring companies to provide their financial statements in interactive data format using the extensible Business Reporting Language, or XBRL. We are required to comply with these rules. Our management and other personnel will need to devote a substantial amount of time and financial resources to comply with these requirements, as well any new requirements implemented by the SEC. Moreover, these rules and regulations will increase our legal and financial compliance costs and will make some activities more time-consuming and costly and could lead to a diversion of management time and attention from revenue generating activities to compliance activities. We are currently unable to estimate these costs with any degree of certainty. These rules and regulations could also make it more difficult for us to attract and retain qualified persons to serve on our board of directors and board committees or as executive officers and more expensive for us to obtain director and officer liability insurance.

 

  11  

 

 

Our common stock is subject to the “Penny Stock” Rules of the SEC and the trading market in our securities is limited, which makes transactions in our stock cumbersome and may reduce the value of an investment in our stock.

 

The SEC has adopted Rule 15g-9 which establishes the definition of a “penny stock,” for the purposes relevant to us, as any equity security that has a market price of less than $5.00 per share or with an exercise price of less than $5.00 per share, subject to certain exceptions. For any transaction involving a penny stock, unless exempt, the rules require: (a) that a broker or dealer approve a person’s account for transactions in penny stocks; and (b) the broker or dealer receive from the investor a written agreement to the transaction, setting forth the identity and quantity of the penny stock to be purchased.

 

In order to approve a person’s account for transactions in penny stocks, the broker or dealer must: (a) obtain financial information and investment experience and objectives of the person; and (b) make a reasonable determination that the transactions in penny stocks are suitable for that person and the person has sufficient knowledge and experience in financial matters to be capable of evaluating the risks of transactions in penny stocks.

 

The broker or dealer must also deliver, prior to any transaction in a penny stock, a disclosure schedule prescribed by the Commission relating to the penny stock market, which, in highlight form: (a) sets forth the basis on which the broker or dealer made the suitability determination; and (b) that the broker or dealer received a signed, written agreement from the investor prior to the transaction. Generally, brokers may be less willing to execute transactions in securities subject to the “penny stock” rules. This may make it more difficult for investors to dispose of our common shares and cause a decline in the market value of our stock.

 

Disclosure also has to be made about the risks of investing in penny stocks in both public offerings and in secondary trading and about the commissions payable to both the broker-dealer and the registered representative, current quotations for the securities and the rights and remedies available to an investor in cases of fraud in penny stock transactions. Finally, monthly statements have to be sent disclosing recent price information for the penny stock held in the account and information on the limited market in penny stocks.

 

The Financial Industry Regulatory Authority (“FINRA”) sales practice requirements may also limit your ability to buy and sell our common stock, which could depress the price of our shares.

 

FINRA has adopted rules that require broker-dealers to have reasonable grounds for believing that an investment is suitable for a customer before recommending that investment to the customer. Prior to recommending speculative low-priced securities to their non-institutional customers, broker-dealers must make reasonable efforts to obtain information about the customer’s financial status, tax status and investment objectives, among other things. Under interpretations of these rules, FINRA believes that there is a high probability such speculative low-priced securities will not be suitable for at least some customers. Thus, FINRA requirements make it more difficult for broker-dealers to recommend that their customers buy our common stock, which may limit your ability to buy and sell our shares, have an adverse effect on the market for our shares, and thereby depress our share price.

 

Since our principal stockholders beneficially own in excess of 83% of our outstanding of common stock, you will not have the ability to determine the outcome of matters requiring stockholder approval, including the acquisition of a target business.

 

Our principal stockholders own in excess of 83% of our outstanding shares of our common stock. As a result, you will not have the ability to determine the outcome of matters requiring the approval of stockholders, including: (a) election of our board of directors; (b) removal of any of our directors; (c) amendments to our Articles of Incorporation or bylaws; (d) adoption of measures that could delay or prevent a change in control or impede a merger, takeover or other business combination involving us, or (e) other significant corporate transactions, including the acquisition of a target business.

 

  12  

 

 

Under our Articles of Incorporation, our Board of Directors has the authority, without stockholder approval, to issue preferred stock with terms that may not be beneficial to common stock holders and with the ability to adversely affect stockholder voting power and perpetuate the board’s control over our company.

 

Our Board of Directors by resolution may authorize the issuance of up to 5,000,000 shares of preferred stock in one or more series with such limitations and restrictions as it may determine, in its sole discretion, with no further authorization by security holders required for the issuance of such shares. The Board may determine the specific terms of the preferred stock, including: designations; preferences; conversions rights; cumulative, relative; participating; and optional or other rights, including: voting rights; qualifications; limitations; or restrictions of the preferred stock.

 

The issuance of preferred stock may adversely affect the voting power and other rights of the holders of common stock. Preferred stock may be issued quickly with terms calculated to discourage, make more difficult, delay or prevent a change in control of our company or make removal of management more difficult. As a result, the Board of Directors’ ability to issue preferred stock may discourage the potential hostile acquirer, possibly resulting in beneficial negotiations. Negotiating with an unfriendly acquirer may result in terms more favorable to us and our stockholders. Conversely, the issuance of preferred stock may adversely affect the market price of, and the voting and other rights of the holders of the common stock. We presently have no plans to issue any preferred stock.

 

We may, in the future, issue additional shares of common stock, which would reduce investors’ percent of ownership and may dilute our share value.

 

Our Articles of Incorporation, as amended, authorizes the issuance of 1,000,000,000 shares of common stock. As of May 10, 2018, we had 79,099,039 shares of common stock outstanding. The future issuance of common stock may result in substantial dilution in the percentage of our common stock held by our then existing stockholders. We may value any common stock issued in the future on an arbitrary basis. The issuance of common stock for future services or acquisitions or other corporate actions may have the effect of diluting the value of the shares held by our investors, and might have an adverse effect on any trading market for our common stock.

 

We do not foresee paying cash dividends on our common stock in the foreseeable future and, as a result, our investors’ sole source of gain, if any, will depend on capital appreciation, if any.

 

We do not plan to declare or pay any cash dividends on our shares of common stock in the foreseeable future. As a result, investors should not rely on an investment in our securities if they require the investment to produce dividend income. Capital appreciation, if any, of our shares may be investors’ sole source of gain for the foreseeable future. Moreover, investors may not be able to resell their shares of our common stock at or above the price they paid for them.

 

ITEM 2. FINANCIAL INFORMATION.

 

The following discussion should be read in conjunction with the financial statements and related notes that appear elsewhere in this prospectus. This discussion contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those anticipated in these forward-looking statements. All forward-looking statements speak only as of the date on which they are made. We undertake no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they are made.

 

  13  

 

 

Management’s Discussion and Analysis or Plan of Operations

 

PBG was organized in August 2016 to explore the market in the United States for wastewater treatment solutions and subsequently expanded its focus to markets outside the United States. On April 3, 2017, PBG entered into the License Agreement with Beijing QHY Environment S&T Co. Ltd., a corporation organized under the laws of the People’s Republic of China, pursuant to which PBG was granted the exclusive right to 21 patents and related technologies related to wastewater treatment solutions. The License was amended in June 2017.

 

To date, PBG has not been adequately capitalized and has relied upon loans from its principal shareholder to pay its expenses. The ability of the Company to continue as a going concern is dependent on the Company’s obtaining adequate capital to fund operating losses until it becomes profitable. If the Company is unable to obtain adequate capital, it could be forced to cease operations.

 

PBG intends to seek to raise the necessary capital to recruit the personnel necessary to commence operations in the United States and internationally and to begin performing under such contracts as it may be granted. Its revenues will be determined by the prices negotiated with those parties that choose to employ its water treatment facilities and further, will be determined by the scope of the products and services agreed to be provided. The Company’s expenses will be determined principally by the costs incurred in performing under any contract, the amount devoted to expenses related to being a public company, such as accounting and legal expenses.

 

There can be no assurance that the Company will be able to enter into contracts for the use of its systems or that it will be able to perform its obligations under such contracts on a profitable basis.

 

During the next 12 months, we anticipate incurring costs for sales and marketing efforts, costs related to initial performance under any contract entered into and costs incurred to file Exchange Act reports. We believe we will be able to meet these costs through amounts, as necessary, to be loaned by or invested in us by our principal stockholders or other investors. We have no specific plans, understandings or agreements with respect to the raising of such funds, and we may seek to raise the required capital by the issuance of equity or debt securities or by other means. Since we have no such arrangements or plans currently in effect, our inability to raise funds for the consummation of an acquisition may have a severe negative impact on our ability to become a viable company.

 

Results of Operations

 

Years ended December 31, 2017 and 2016

 

PBG was organized in August 2016. During the remainder of 2016 and all of 2017 its activities were limited to the exploration of the markets for wastewater treatment within and outside the United States. The Company sold no products and performed no services during such period and consequently, generated no revenues. The expenses incurred primarily related to those costs and expenses incurred by its representatives in exploring the market, and meeting with prospective customers and employees to determine their interest in using the products available pursuant to the License Agreement or working for the Company, and professional fees incurred in connection with the Company’s organization and initial activities.

 

Total operating expenses were $207,504 and $12,212 for the years ended December 31, 2017, and 2016, respectively. The increase in operating expenses for the year ended December 31, 2017 reflects a substantial increase in the level of the Company’s exploratory activities in 2017 as compared to 2016.

 

  14  

 

 

Liquidity and Capital Resources

 

Liquidity is the ability of a company to generate funds to support its current and future operations, satisfy its obligations, and otherwise operate on an ongoing basis. As of December 31, 2017, we had $0 in cash. We have not generated revenues to fund our operating expenses since formation and have had to rely upon contributions from our stockholders. We need to obtain financing to commence operations and satisfy our cash needs for the next 12 months. In all likelihood, for the foreseeable future, we will remain dependent upon our management and stockholders to fund our cash needs.

 

We have entered into a Credit Loan Agreement with Dragon & Tiger Holding Limited (“D&T”), one of our shareholders, which is controlled by Roy Teng. Pursuant to the agreement, D&T has agreed to lend us up to $500,000. All amounts borrowed are to bear interest at the rate of 10% per annum. Accrued interest through the end of 2018 and 2019 and is to be paid no later than 90 days after the end of each year. All amounts borrowed and are to be repaid in full on or before May 1, 2020. In addition to interest, D&T will be issued three-year warrants to purchase 50,000,000 shares of the registrant’s common stock at a price of $0.01 per share. The warrants cannot be exercised before April 1, 2019, and shall be void and non-exercisable if the Company (i) raises more than $20 million in equity or (ii) has revenue in excess of $100 million in any fiscal year. To date, D&T has advanced an aggregate of $198,730.

 

The following table summarizes the Company’s cash flows for the years ended December 31, 2017 and 2016:

 

    Year ended December 31  
    2017     2016  
Net cash used in operating activities   $ (163,504 )   $ (7,212 )
Net cash provided by investing activities     -       -  
Net cash provided by financing activities     163,504       7,212-  
Net increase in cash and cash equivalents   $ -     $ -  

 

Going Concern Consideration

 

The Company's financial statements are prepared using accounting principles generally accepted in the United States of America applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has not yet established an ongoing source of revenues sufficient to cover its operating costs and allow it to continue as a going concern. The ability of the Company to continue as a going concern is dependent on the Company’s obtaining adequate capital to fund operating losses until it becomes profitable. If the Company is unable to obtain adequate capital, it could be forced to cease operations.

 

In order to continue as a going concern, the Company will need, among other things, additional capital resources. Management's plans to obtain such resources for the Company include (1) obtaining capital from management and significant stockholders sufficient to meet its minimal operating expenses, and (2) seeking out and completing a merger with an existing operating company. However, management cannot provide any assurances that the Company will be successful in accomplishing any of its plans.

 

The ability of the Company to continue as a going concern is dependent upon its ability to successfully accomplish the plans described in the preceding paragraph and eventually secure other sources of financing and attain profitable operations. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. 

 

  15  

 

 

Critical Accounting Policies

 

The discussion and analysis of our financial condition and results of operations are based upon our financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles. The preparation of our financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an on-going basis, we evaluate our estimates based on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

 

Management believes the following critical accounting policies affect the significant judgments and estimates used in the preparation of the financial statements.

 

Use of estimates

 

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

Management makes these estimates using the best information available at the time the estimates are made; however, actual results could differ from those estimates.

 

Income Taxes

 

Current income taxes are provided for in accordance with the laws of the relevant taxing authorities. As part of the process of preparing financial statements, the Company is required to estimate its income taxes in each of the jurisdictions in which it operates. The Company accounts for income taxes using the assets and liability method. Under this method, deferred income taxes are recognized for tax consequences in future years of differences between the tax bases of assets and liabilities and their reported amounts in the financial statements at each year-end. Deferred tax assets and liabilities are measured using enacted tax rates applicable for the differences that are expected to affect taxable income.

 

The Company adopts a more likely than not threshold and a two-step approach for the tax position measurement and financial statement recognition. Under the two-step approach, the first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained, including resolution of related appeals or litigation process, if any. The second step is to measure the tax benefit as the largest amount that is more than 50% likely of being realized upon settlement. As of December 31, 2017 and 2016, the Company did not have any uncertain tax positions.

 

Functional currency and foreign currency translation and transactions

 

The Company’s functional and reporting currency is the U.S. dollar (“US$”). Transactions denominated in currencies other than the functional currency are translated into prevailing functional currency at the exchange rates prevailing at the late date of the months the transactions occurred. The Company had no monetary assets and liabilities denominated in foreign currencies at the balance sheet dates.

 

  16  

 

 

Related parties

 

Parties are considered to be related if one party has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Parties are also considered to be related if they are subject to common control or significant influence, such as a family member or relative, stockholder, or a related corporation.

 

Off-Balance Sheet Arrangements

 

The Company has no off-balance sheet arrangements.

 

ITEM 3. PROPERTIES.

 

The Company currently maintains a corporate office at Suite 1515, 1501 Broadway, New York, NY, 10036. The office is provided to us by Pluris Capital Group, an entity affiliated with Roy Teng, as part of a financial advisory agreement pursuant to which we pay Pluris $30,000 per quarter. The agreement has a term of five years but is cancellable by either party on sixty days’ notice. Our telephone number is (212) 324 1876.

 

ITEM 4. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT.

 

The following table sets forth, as of May 10, 2018, the number of shares of our common stock beneficially owned by (i) each person or entity known to us to be the beneficial owner of more than 5% of the outstanding common stock; (ii) each of our directors and officers, and (iii) all of our officers and directors as a group. Information relating to beneficial ownership of common stock by our principal stockholders and management is based upon information furnished by each person using beneficial ownership concepts under the rules of the Securities and Exchange Commission. Under these rules, a person is deemed to be a beneficial owner of a security if that person has or shares voting power, which includes the power to vote or direct the voting of the security, or investment power, which includes the power to vote or direct the voting of the security. The person is also deemed to be a beneficial owner of any security of which that person has a right to acquire beneficial ownership within 60 days.

 

Under the Securities and Exchange Commission rules, more than one person may be deemed to be a beneficial owner of the same securities, and a person may be deemed to be a beneficial owner of securities as to which he or she may not have any pecuniary beneficial interest. Each beneficial owner's percentage ownership is determined by assuming that options or warrants that are held by such person (but not those held by any other person) and which are exercisable within 60 days from the date of this report have been exercised. Except as noted below, each person has sole voting and investment power.

 

As of May 10, 2018, we had outstanding 79,099,039 shares of common stock. We do not have any outstanding options, or other securities exercisable for or convertible into shares of our common stock.

 

Name of Stockholder   Amount and Nature of Beneficial Ownership     Percent of Class  
Our Directors and Executive Officers:            
Mao Xu     32,919,719       41.62 %
Yu Tao     16,459,860       20.81 %
Dragon & Tiger Holding Limited     16,459,860       20.81 %
Jin Siming     -       -  
All Directors and Executive Officers as a group     65,839,439       83.24 %
                 
Other Owners of More than 5% of Common Stock:                
Song Yakun     9,100,000       11.50 %

 

  17  

 

 

ITEM 5. DIRECTORS AND EXECUTIVE OFFICERS.

 

The table below sets forth the name and age of each executive officer and director of the Company and the date such executive officer or director was elected to his current position with the Company. There is no family relationship between the executive officers.

 

Name   Age     Positions
Mao Xu     53     Chairman of the Board and Chief Executive Officer
Roy Teng     39     Director
Yu Tao     52     Director
Jin Siming     29     Secretary

 

Mao Xu

 

Mr. Mao Xu has served as our Chief Executive Officer and Chairman of the Board since March 29, 2018. Mr. Mao has over 25 years’ experience managing and operating companies of various sizes in stages of development, including a number of companies he founded. Mr. Mao served as General Manager of Beijing Shuanglong Aviation Service Company from 1993 to 2002, and chairman of Beijing Tianxing Futures Brokerage Company Limited from 1997 to 2008. Since 2000 Mr. Mao has served as chairman of Citron Holdings Limited. In 2001, Mr. Mao became chairman of Orient Xiehe Medical Bio-technology Company Limited, a position which he continues to hold. Mr. Mao has been involved in chemical and molecular products research and operations since 2001, and has been focused on wastewater treatment research, application and project management for 5 years. Mr. Mao received an associate degree on law from China University of Political Science and Law.

 

Roy Teng

 

Mr. Roy Teng has been a Director of our company since March 29, 2018. Mr. Teng is responsible for advising on and supervising the implementation of strategic investment planning of our Group. Mr. Teng has over ten years of experience in the field of finance. From August 2004 to December 2006, Mr. Teng worked as vice president of corporate development for China Digital Communication Group, a manufacturer of battery shells and related technology for use in electronic products, primarily mobile phones. From December 2006 to October 2008, Mr. Teng served as managing director at China Finance Inc. From October 2008 to June 2014, Mr. Teng served as president of the China region and managing director of investment banking of Brean Capital, LLC, a boutique investment bank. Mr. Teng has been the legal representative of Leshan Ruijin Investment Management Company Limited since August 2011 and the general manager since June 2014. Mr. Teng obtained his bachelor’s degree of science in management and his master’s degree of science in international business from Arizona State University and California International University in May 2002 and June 2004, respectively. Mr. Teng also received a Post Baccalaureate Certificate in Accountancy from Arizona State University West in May 2003 and a Master of Business Administration from Peking University in July 2015.

 

  18  

 

 

Yu Tao

 

Mr. Yu Tao has been a Director of our company since March 29, 2018. Mr. Yu has over 18-years’ experience in managing and operating companies in various industries in China, a number of which he formed. Since 2001 Mr. Yu has served as chairman of Beijing Huarong Hengtai Trade Company Limited. Beginning in 2003, Mr. Yu began to serve as chairman of Beijing Wantong World Real Estate Company Limited, a real estate acquisition and development company. Since 2014, Mr. Yu has served as chairman of Beijing Wanrong Century Properties Company Limited. Mr. Yu received a bachelor degree in Chinese Literature from Shanxi University in year 1989.

 

Jin Siming

 

Mr. Jin Siming served as our President, Chief Executive Officer and Secretary from July 2014 to March 2018, and continues to serve as our Secretary. Mr. Jin is experienced in corporate finance and the general affairs of public companies. Since 2013 Mr. Jin has served as a manager of Leshan Ruijin Investment Management Company Limited. Mr. Jin received a bachelor degree in International Economics and Trade from Xiamen University in 2012.

 

Board Composition

 

Our bylaws provide that the Board of Directors shall consist of one or more members. Each director of the Company serves for a term of one year or until his successor is elected at the Company’s annual stockholders’ meeting and is qualified, subject to removal by our stockholders. Each officer serves at the pleasure of the Board of Directors, for a term of one year and until his successor is elected at the annual meeting of the Board of Directors.

 

Significant Employees

 

Other than the above-named officers and directors, we have no full-time employees whose services are materially significant to our business and operations.

 

Family Relationships

 

There are no familial relationships among any of our officers or directors. None of our directors or officers is a director in any other reporting companies except disclosed. The Company is not aware of any proceedings to which any of the Company‚ officers or directors, or any associate of any such officer or director, is a party adverse to the Company or any of the Company‚ subsidiaries or has a material interest adverse to it or any of its subsidiaries.

 

Involvement in Legal Proceedings

 

None.

 

ITEM 6. EXECUTIVE COMPENSATION.

 

The following table sets forth information concerning all cash and non-cash compensation awarded to, earned by or paid to our chief executive officer for services rendered in all capacities for the periods set forth below. No executive officer of our company received total annual salary and bonus compensation during the fiscal year ended December 31, 2017, for services rendered in all capacities during the fiscal year ended December 31, 2017. 

 

  19  

 

 

Summary Compensation Table

 

                                                  Nonqualified              
                                            Non-Equity     Deferred              
Name and                             Stock       Option     Incentive Plan     Compensation     All Other        
Principal                     Bonus       Awards       Awards     Compensation     Earnings     Compensation     Total  
Position     Year       Salary       ($)       ($)       ($)     ($)     ($)     ($)     ($)  
                                                                 
Jin Siming     2017       None       None       None       None     None     None     None     None  
President, CEO, Secretary     2016       None       None       None       None     None     None     None     None  

 

 

*Jin Siming served as our President and Chief Executive Officer until March 29, 2018.

 

Employment Agreements

 

We do not have any employment agreements with any of our officers and directors, some of whom have performed services on our behalf for no compensation.

 

Compensation of Directors

 

Our board of directors has not received any compensation to date.

 

None of our executive officers or directors received equity awards, including, options, restricted stock or other equity incentives during the fiscal year ended December 31, 2017, or held any equity awards at December 31, 2017.

 

ITEM 7. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE.

 

Related Party Transactions

 

During the years ended December 31, 2017 and 2016, we received advances of $163,504 and $7,212 from Dragon & Tiger Holding Limited, one of our stockholders, which is controlled by Roy Teng. We entered into a Credit Loan Agreement with D&T pursuant to which D&T has agreed to lend us up to $500,000. All amounts borrowed are to bear interest at the rate of 10% per annum. Accrued interest through the end of 2018 and 2019 and is to be paid no later than 90 days after the end of each year. All amounts borrowed and are to be repaid in full on or before May 1, 2020. In addition to interest, D&T will be issued three-year warrants to purchase 50,000,000 shares of the registrant’s common stock at a price of $0.01 per share. The warrants cannot be exercised before April 1, 2019, and shall be void and non-exercisable if the Company (i) raises more than $20 million in equity or (ii) has revenue in excess of $100 million in any fiscal year. To date, D&T has advanced an aggregate of $198,730.

 

Mr. Mao Xu, our founder and a principal shareholder, is the founder and controlling shareholder of Beijing QHY Environment S & T Co. Ltd. We licensed the technologies on which our business is based from Mr. Mao and Beijing QHY. The License Agreement, as amended, requires that we pay Beijing QHY $1 million on or before December 31, 2021 and running royalties of 1% of our net revenues, as defined in the License. The Company recorded $37,500 license fee expense for the year ended December 31, 2017, and made no payment of license fee as of December 31, 2017. No purchase was made by the Company from the Licensor during the year ended December 31, 2017.

 

  20  

 

 

We currently maintain a corporate office at Suite 1515, 1501 Broadway, New York, NY, 10036. The office is provided to us by Pluris Capital Group, an entity affiliated with Dragon & Tiger Holding Limited, as part of a financial advisory agreement pursuant to which we pay Pluris $30,000 per quarter. The agreement has a term of five years but is cancellable by either party on sixty days’ notice. Our telephone number is (212) 324 1876.

 

Promoters and Certain Control Person

 

Each of Messrs. Mao, Teng and Yu could be considered a promoter of our company.

 

Director Independence

 

We currently do not have any independent directors, as the term “independent” is defined by the rules of the Nasdaq Stock Market.

 

ITEM 8. LEGAL PROCEEDINGS.

 

None.

 

Item 9. Market Price of and Dividends on the Registrant’s Common Equity and Related Stockholder Matters.

 

Market Information

 

Our common stock is quoted on OTC Pink under the symbol "YIHG"; however; an active trading market for our shares does not exist.

 

Penny Stock Regulations

 

Trading in our shares is subject to the provisions of Section 15(g) and Rule 15g-9 of the Securities Exchange Act of 1934, as amended (the Exchange Act"), commonly referred to as the "penny stock" rule. Section 15(g) sets forth certain requirements for transactions in penny stocks and Rule 15g9(d)(1) incorporates the definition of penny stock as that used in Rule 3a51-1 of the Exchange Act.

 

The Securities and Exchange Commission (the “Commission”) generally defines penny stock to be any equity security that has a market price less than $5.00 per share, subject to certain exceptions. Rule 3a51-1 provides that any equity security is considered to be a penny stock unless that security is: registered and traded on a national securities exchange meeting specified criteria set by the Commission; authorized for quotation on The NASDAQ Stock Market; issued by a registered investment company; excluded from the definition on the basis of price (at least $5.00 per share) or the registrant's net tangible assets; or exempted from the definition by the Commission. Trading in the shares is subject to additional sales practice requirements on broker-dealers who sell penny stocks to persons other than established customers and accredited investors, generally persons with assets in excess of $1,000,000 or annual income exceeding $200,000, or $300,000 together with their spouse.

 

For transactions covered by these rules, broker-dealers must make a special suitability determination for the purchase of such securities and must have received the purchaser's written consent to the transaction prior to the purchase. Additionally, for any transaction involving a penny stock, unless exempt, the rules require the delivery, prior to the first transaction, of a risk disclosure document relating to the penny stock market. A broker-dealer also must disclose the commissions payable to both the broker-dealer and the registered representative, and current quotations for the securities. Finally, the monthly statements must be sent disclosing recent price information for the penny stocks held in the account and information on the limited market in penny stocks. Consequently, these rules may restrict the ability of broker dealers to trade and/or maintain a market in the Company's common stock and may affect the ability of shareholders to sell their shares.

 

  21  

 

 

Holders

 

As of May 10, 2018, there were approximately 38 holders of record of our common stock.

 

Warrants

 

Except for warrants to purchase 50,000,000 shares of our common stock to be issued to Dragon & Tiger Holding Limited, an entity controlled by Mr. Teng, as part of the consideration for a loan of up to $500,000, we have not issued any derivative securities, nor are there any warrants, options or other convertible securities outstanding.

 

Dividends

 

Any decisions regarding dividends will be made by our board of directors. We currently intend to retain and use any future earnings for the development and expansion of our business and do not anticipate paying any cash dividends in the foreseeable future. Our board of directors has complete discretion on whether to pay dividends, subject to the approval of our stockholders. Even if our board of directors decides to pay dividends, the form, frequency and amount will depend upon our future operations and earnings, capital requirements and surplus, general financial condition, contractual restrictions and other factors that the board of directors may deem relevant.

 

Purchases of Our Equity Securities

 

Neither we nor any of our affiliates purchased any equity securities from our shareholders during the fiscal year ended December 31, 2017.

 

Item 10. Recent Sales of Unregistered Equity Securities.

 

We issued 46,839,439 shares of common stock and 19,000 shares of Series A Preferred Stock to the holders of PBG Water Solutions Inc. pursuant to the Exchange Agreement. All of the recipients of our shares were non-U.S. Persons (as defined in Rule 902(k) of Regulation S and the third was an accredited investor (as defined in Regulation D). Consequently, the issuance was exempt from the registration requirements of the Securities Act pursuant to the exemptions provided by Regulation S and Regulation D. Each share of Series A Preferred Stock was automatically converted into 1,000 shares of common stock on April 18, 2018 upon the filing of a certificate of amendment to our Articles of Incorporation increasing the authorized shares of our common stock to 1,000,000,000 shares. The certificates representing all of the foregoing shares were endorsed with the customary restrictive Regulation S and Regulation D legends, as appropriate.

 

We issued warrants to purchase 50,000,000 shares of our common stock to Dragon & Tiger Holding Limited, an entity controlled by Mr. Teng, as part of the consideration for a loan of up to $500,000. The warrants cannot be exercised before April 1, 2019, and shall be void and non-exercisable if the Company (i) raises more than $20 million in equity or (ii) has revenue in excess of $100 million in any fiscal year. Mr. Teng is an accredited investor and the Warrant Agreement was endorsed with the customary restrictive Regulation D legends and, if appropriate, the shares issuable upon exercise of the warrants will be endorsed with the customary restrictive Regulation D legends.

 

  22  

 

 

Item 11. Description of Registrant’s Securities to be Registered.

 

The Company is authorized to issue up to 1,000,000,000 shares of common stock, $0.001 par value. As of May 10, 2018, we had outstanding 79,099,039 shares of common stock. The holders of our Common Stock are entitled to one vote per share held and have the sole right and power to vote on all matters on which a vote of stockholders is taken. Voting rights are non-cumulative. Common stockholders are entitled to receive dividends when, as, and if declared by the Board of Directors, out of funds legally available therefore and to share pro rata in any distribution to stockholders. Upon liquidation, dissolution, or the winding up of our Company, common stockholders are entitled to receive the net assets of our Company in proportion to the respective number of shares held by them after payment of liabilities which may be outstanding. The holders of common stock do not have any preemptive right to subscribe for or purchase any shares of any class of stock of the Company. The outstanding shares of common stock will not be subject to further call or redemption and are fully paid and non-assessable. To the extent that additional common shares are issued, the relative interest of existing stockholders will likely be diluted.

 

Our Articles of Incorporation authorize the issuance by resolution of our Board of Directors of up to five million shares of “blank-check” preferred stock in one or more series, the terms of which may be determined at the time of issuance as the Board of Directors may determine, in its sole discretion, without further authorization by our stockholders. These terms could give the holders of the preferred stock the right to vote as a series on particular matters, preferences ass to dividends and upon liquidation, conversion rights, redemption rights and sinking fund provisions. The terms of any series of preferred may not be beneficial to common stock holders, since they may adversely affect the voting power and diminish other rights of holders of our common stock and perpetuate the board's control over our company, and therefore could reduce the value of such common stock. Preferred stock may be issued quickly with terms calculated to discourage, make more difficult, delay or prevent a change in control of our company or make removal of management more difficult. In addition, specific rights granted to future holders of preferred stock could be used to restrict our ability to merge with, or sell assets to, a third party. The ability of our board of directors to issue preferred stock could make it more difficult, delay, discourage, prevent or make it more costly to acquire or effect a change-in-control, which in turn could prevent our stockholders from recognizing a gain in the event that a favorable offer is extended and could materially and negatively affect the market price of our common stock.

 

Transfer Agent

 

Globex Transfer, LLC

780 Deltona Blvd., Suite 202

Deltona, FL 32725

(813)344-4490

Fax (386)267-3124

 

Item 12. Indemnification of Directors and Officers.

 

Our officers and directors are indemnified as provided by the Nevada Business Corporation Act and our Articles of Incorporation

 

  23  

 

 

Under the Nevada Business Corporation Act, director immunity from liability to a company or its shareholders for monetary liabilities applies automatically unless it is specifically limited by a company’s Articles of Incorporation. Our Articles of Incorporation do not specifically limit our directors’ immunity. Excepted from that immunity are: (a) a willful failure to deal fairly with the company or its stockholders in connection with a matter in which the director has a material conflict of interest; (b) a violation of criminal law, unless the director had reasonable cause to believe that his or her conduct was lawful or no reasonable cause to believe that his or her conduct was unlawful; (c) a transaction from which the director derived an improper personal profit; and (d) willful misconduct.

 

Our Articles of Incorporation provide that we will indemnify our directors and officers to the fullest extent permitted by law, provided, however, that we may modify the extent of such indemnification by individual contracts with our directors and officers; and, provided, further, that we shall not be required to indemnify any director or officer in connection with any proceeding, or part thereof, initiated by such person unless such indemnification: (a) is expressly required to be made by law, (b) the proceeding was authorized by our board of directors, (c) is provided by us, in our sole discretion, pursuant to the powers vested in us under law or (d) is required to be made pursuant to the bylaws.

 

Item 13. Financial Statements and Supplementary Data.

 

The financial statements required by this Item begin on page F-1.

 

Item 14. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.

 

None.

 

Item 15. Financial Statements and Exhibits.

 

(a) Financial Statements and Schedules

 

The consolidated financial statements required to be filed as part of this Registration Statement are included in Item 13 hereof.

 

(b) Exhibits

 

Exhibit No.     Description
     
2.1      Exchange Agreement.
3.1      Articles of Incorporation. (Incorporated by reference to Exhibit 3.1 to the Registrant’s Registration Statement on Form S-1/A Amendment No. 1 filed March 14, 2008 .
3.2   Certificate of Amendment to Articles of Incorporation changing the name of the Registrant  (Incorporated by reference to Exhibit 3.1 to the Registrant’s Report on Form 8-K/A dated September 13, 2011).
3.3   Certificate of Amendment to Articles of Incorporation changing the name of the Registrant  (Incorporated by reference to Exhibit 3.2 to the Registrant’s Report on Form 10-K dated September 13, 2011).
3.4   Amended and Restated By Laws Registrant  (Incorporated by reference to Exhibit 3.2 to the Registrant’s Report on Form 10-K filed March 30, 2012).
10.1      License and Requirement Supply Agreement among PBG Water Solutions International, Inc., Beijing QHY Environment S & T Co. Ltd. and Mao Xu.
10.2   Amendment to License and Supply Agreement PBG Water Solutions International, Inc., Beijing QHY Environment S & T Co. Ltd. and Mao Xu.

10.3

  Credit Loan Agreement PBG Water Solutions International, Inc., the Registrant and Dragon & Tiger Holding Limited.
10.4   Warrant issued to Dragon & Tiger Holding Limited.
21.1   Subsidiaries

 

  24  

 

 

SIGNATURES

 

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  Yakun International Investment and Holding Group
     
Date: May 14, 2018 By: /s/ Mao Xu
    Mao Xu
    Chief Executive Officer (principal executive officer)

 

  25  

 

 

 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the board of Directors and Shareholders of
PBG Water Solutions International Inc.

 

We have audited the accompanying balance sheets of PBG Water Solutions International Inc. (the “Company”) as of December 31, 2017 and 2016 and the related statements of operations and comprehensive loss, changes in stockholders’ equity and cash flows, for the year ended December 31, 2017 and the period from August 4, 2016 (incorporation date) to December 31, 2016. These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements based on our audits.

 

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of internal control over financial reporting. Our audit included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

 

In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of PBG Water Solutions International Inc. as of December 31, 2017 and 2016, and the results of their operations and their cash flows, for the year ended December 31, 2017 and the period from August 4, 2016 (incorporation date) to December 31, 2016, in conformity with accounting principles generally accepted in the United States of America.

 

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 to the financial statements, the Company has suffered operating loss and has experienced negative cash flows from operations, which raises substantial doubt about the Company's ability to continue as a going concern. Management's plans in regard to those matters are also described in Note 2 to the financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

/s/ Yu Certified Public Accountant, P.C.

New York, New York

May 14, 2018

 

 

Certified Public Accountants

99 Madison Avenue, Suite 601, New York NY 10016

Tel: 347-618-9237, 516-778-6818

Email: Info@ywlcpa.com

 

  F- 1  

 

 

PBG Water Solutions International Inc.

BALANCE SHEETS

(Expressed in U.S. dollars)

 

    As of December 31,  
    2017     2016  
ASSETS            
Total assets   $ -     $ -  
                 
LIABILITIES AND STOCKHOLDERS’ EQUITY                
                 
Current liabilities                
Accounts payable     11,500       5,000  
Due to related parties     208,216       7,212  
Total current liabilities     219,716       12,212  
                 
Stockholders’ deficit                
Common stock, $0.0001 par value; 100,000,000 shares authorized, 100 shares issued and outstanding at December 31, 2017 and December 31, 2016     -       -  
Retained earnings     (219,716 )     (12,212 )
Total stockholders' deficit     (219,716 )     (12,212 )
                 
Total liabilities and stockholders’ deficit   $ -     $ -  

 

See notes to the financial statements.

  

  F- 2  

 

 

PBG Water Solutions International Inc.

STATEMENTS OF OPERATIONS AND CONPREHENSIVE INCOME

(Expressed in U.S. dollars)

 

    Year ended
December 31, 2017
    Period from August 4,
2016 (Incorporation Date)
to December 31, 2016
 
Revenue   $ -     $ -  
Cost of Revenue     -       -  
Gross profit     -       -  
                 
Expenses                
Professional fees     35,950       5,000  
Professional fees – related party     114,402       -  
License and royalty fee     37,500       -  
General and administrative     19,652       7,212  
Total expenses     207,504       12,212  
                 
Net loss   $ (207,504 )   $ (12,212 )
                 
Other comprehensive income     -       -  
Total comprehensive income     (207,504 )     (12,212 )
                 
Earnings per share – basic and diluted   $ (2,075.04 )   $ (122.12 )
Weighted average number of shares outstanding – basic and diluted     100       100  

   

See notes to the financial statements

   

  F- 3  

 

  

PBG Water Solutions International Inc.

STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT

(Expressed in U.S. dollars)

 

    Common Stocks     Retained     Total Stockholders’  
    Shares     Amount     earnings     deficit  
                         
Balance as of August 4, 2016     -     $ -     $ -     $      -  
                                 
Stock issuance     100       -       -       -  
Net loss for the year     -       -       (12,212 )     (12,212 )
Balance as of December 31, 2016     100     $ -     $ (12,212 )   $ (12,212 )
                                 
Net loss for the year     -       -       (207,504 )     (207,504 )
Balance as of December 31, 2017     100     $ -     $ (219,716 )   $ (219,716 )

 

See notes to the financial statements

   

  F- 4  

 

 

PBG Water Solutions International Inc.

STATEMENTS OF CASH FLOWS

(Expressed in U.S. dollars)

 

    Year ended
December 31,
2017
    Period from
August 4, 2016
(Incorporation
Date) to
December 31,
2016
 
Cash flows from operating activities                
Net loss   $ (207,504 )   $ (12,212 )
Adjustments to reconcile net loss to net cash used in operating activities:                
Changes in operating assets and liabilities:     -       -  
Accounts payable     6,500       5,000  
License fee payable – related party     37,500       -  
Net cash used in operating activities     (163,504 )     (7,212 )
                 
Net cash provided by investing activities     -       -  
                 
Cash flows from financing activities                
Due to related parties     163,504       7,212  
Net cash provided by financing activities     163,504       7,212  
                 
Net increase in cash and cash equivalents     -       -  
Cash and cash equivalents at beginning of year     -       -  
Cash and cash equivalents at end of year   $ -     $ -  
                 
Supplemental disclosure of cash flow information                
Income taxes paid   $ -     $ -  
Interest paid   $ -     $ -  

 

See notes to the financial statements

  

  F- 5  

 

 

PBG Water Solutions International Inc.

NOTES TO FINANCIAL STATEMENTS

(Expressed in U.S. dollars)

  

  1. Organization and principal activities

 

PBG Water Solutions International Inc. (the “Company”, “PBG Water Solutions” or “we”) was incorporated under the law of the State of Delaware on August 4, 2016, and in October 2017, it merged into a company with the same name incorporated under the law of the State of Nevada on October 18, 2017. PBG Water Solutions is engaged in developing wastewater treatment and solution technics and business.

 

In November 2017, the Company and its shareholders entered into a Share Exchange Agreement (the “ SEA”) with Yakun International Investment & Holding Group (the “Yakun International”), pursuant to which Yakun International will acquired 100% of the outstanding shares of the Company in exchange for 46,839,439 shares of common stocks of Yakun International and 19,000 shares of Series A Convertible Preferred Stocks (each Series A Convertible Preferred Stock is convertible into 1,000 share of common stock) of Yakun International, which will constitute approximately 83% of Yakun International’s issued and outstanding capital stock on a fully-diluted basis as of and immediately after the consummation of the acquisition pursuant to the SEA.

 

Emerging Growth Company

 

Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a Company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth Company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. 

 

  2. Going concern

 

The Company's financial statements are prepared using accounting principles generally accepted in the United States of America applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has not yet established an ongoing source of revenues sufficient to cover its operating costs and allow it to continue as a going concern. The ability of the Company to continue as a going concern is dependent on the Company’s obtaining adequate capital to fund operating losses until it becomes profitable. If the Company is unable to obtain adequate capital, it could be forced to cease operations.

 

  F- 6  

 

 

In order to continue as a going concern, the Company will need, among other things, additional capital resources. Successful completion of the Company’s engagement in water solutions business and its transition to attaining profitable operations, is dependent upon obtaining additional financing by the Company and Yakun International. The Company and Yakun International plan to improve its future liquidity by obtaining additional financing through the issuance of financial instruments such as equity and warrants or through credit loans. Additional financing may not be available on acceptable terms or at all. If Yakun International issues additional equity securities to raise funds, the ownership percentage of existing stockholders would be reduced. New investors may demand rights, preferences or privileges senior to those of existing holders of common stock.

 

The ability of the Company to continue as a going concern is dependent upon its ability to successfully accomplish the plans described in the preceding paragraph and eventually secure other sources of financing and attain profitable operations. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. 

 

  3. Summary of significant accounting policies

 

  (a) Basis of presentation

 

The accompanying financial statements have been presented in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”).

 

  (b) Use of estimates

 

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

Management makes these estimates using the best information available at the time the estimates are made; however, actual results could differ from those estimates.

 

  F- 7  

 

 

  (c) Income Taxes

 

Current income taxes are provided for in accordance with the laws of the relevant taxing authorities. As part of the process of preparing financial statements, the Company is required to estimate its income taxes in each of the jurisdictions in which it operates. The Company accounts for income taxes using the assets and liability method. Under this method, deferred income taxes are recognized for tax consequences in future years of differences between the tax bases of assets and liabilities and their reported amounts in the financial statements at each year-end. Deferred tax assets and liabilities are measured using enacted tax rates applicable for the differences that are expected to affect taxable income.

 

The Company adopts a more likely than not threshold and a two-step approach for the tax position measurement and financial statement recognition. Under the two-step approach, the first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained, including resolution of related appeals or litigation process, if any. The second step is to measure the tax benefit as the largest amount that is more than 50% likely of being realized upon settlement. As of December 31, 2017 and 2016, the Company did not have any uncertain tax positions.

 

  (d)  Functional currency and foreign currency translation and transactions

 

The Company’s functional and reporting currency is the U.S. dollar (“US$”). Transactions denominated in currencies other than the functional currency are translated into prevailing functional currency at the exchange rates prevailing at the late date of the months the transactions occurred. The Company had no monetary assets and liabilities denominated in foreign currencies at the balance sheet dates.

 

  (e)  Loss per share

 

Basic loss per share is computed using the weighted average number of common shares outstanding during the year. Diluted loss per share is computed using the weighted average number of common shares and potential common shares outstanding during the period for options and restricted shares under treasury stock method and for convertible debts under if-convertible method, if dilutive. Potential common shares are not included in the denominator of the diluted earnings per share calculation when inclusion of such shares would be anti-dilutive, such as in a period in which a net loss is recorded. The Company has no potential common shares outstanding as of December 31, 2017 and 2016.

 

  (f)  Related parties

 

Parties are considered to be related if one party has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Parties are also considered to be related if they are subject to common control or significant influence, such as a family member or relative, stockholder, or a related corporation.

 

  F- 8  

 

 

  (g)  Recently issued accounting standards not yet adopted

 

The Company reviews new accounting standards as issued. Although some of these accounting standards issued or effective after the end of the Company’s previous fiscal year may be applicable to the Company, it has not identified any standards that it believes merit further discussion. The Company does not expect the adoption of any recently issued accounting pronouncements to have a significant impact on its financial position, results of operations, or cash flows.

 

  4. Related party transactions and balances  

 

  a) Related party transactions:

 

    Year ended
December 31,
2017
    Period from August 4, 2016
(Incorporation Date) to
December 31, 2016
 
Loan from a shareholder   $ 163,504     $ 7,212  
Fee for professional service provided by a director     114,402       -  
License fee expense to a shareholder     37,500       -  

 

Loan from a shareholder was a non-interest bearing fund from one of Company’s shareholder to pay for the Company and subsidiary’s expenses during the year ended December 31, 2017 and the period from inception to December 31, 2016. The shareholder owned 25% common stocks of the Company.

 

The Company’s sole director from inception to December 31, 2017 is an attorney and provided legal services to the Company during the year ended December 31, 2017 with a service fee of $114,402.

 

In April 2017, the Company ended into a License and Supply Agreement with an individual shareholder who owned 50% of the Company’s common stocks and the shareholder’s majority owned company Beijing QHY Environment S & T Co., Ltd. (Beijing QHY). Pursuant to the License and Supply Agreement and its Amendment in June 2017, the individual shareholder and Beijing QHY (the “Licensor”) granted the exclusive use of 21 intellectual properties in any area outside People’s Republic of China (the “PRC”) for 20 years. License fee, which is a one-time fee of $1 million which shall be paid before December 31, 2021, and 1% of the net revenue the Company received from the sales, license or other distributions of the licensed products which shall be paid annually. In addition, the Licensor shall supply the Company licensed products at price agreed or adjusted by the Licensor and the Company. The Company didn’t generate any net revenue from nor made any purchase of the licensed products during the year ended December 31, 2017. The Company recorded $37,500 license fee expense for the year ended December 31, 2017, and made no payment of license fee as of December 31, 2017. No purchase was made by the Company from the Licensor during the year ended December 31, 2017.

  

  F- 9  

 

  

  b) Related party payables

 

    December 31,  
    2017     2016  
Due to shareholders   $ 208,216     $ 7,212  

 

  5. Income taxes

 

We did not provide any current or deferred U.S. federal income tax provision or benefit for any of the periods presented because we have experienced operating losses. When it is more likely than not that a tax asset cannot be realized through future income the Company must allow for this future tax benefit. We provided a full valuation allowance on the net deferred tax asset, consisting of net operating loss carryforwards, because management has determined that it is more likely than not that we will not earn income sufficient to realize the deferred tax assets during the carryforward period.

 

The Company has not taken a tax position that, if challenged, would have a material effect on the financial statements for the twelve-months ended December 31, 2017 and 2016, or during the prior three years applicable under FASB ASC 740. We did not recognize any adjustment to the liability for uncertain tax position and therefore did not record any adjustment to the beginning balance of accumulated deficit on the balance sheet. All tax returns have been appropriately filed by the Company.

 

Income tax provision at the federal statutory rate     21 %
Effect of operating losses     (21 %)
      - %

 

Net deferred tax assets consist of the following:

 

    December 31,  
    2017     2016  
Net operating loss carry forward   $ 46,140     $ 2,564  
Valuation allowance     (46,140 )     (2,564 )
Net deferred tax asset   $ -     $ -  

 

  F- 10  

 

 

A reconciliation of income taxes computed at the statutory rate is as follows:

 

    Year ended
December 31,
2017
    Period from August 4,
2016 (Incorporation
Date) to December 31,
2016
 
Tax at statutory rate (21%)   $ 43,576     $ 2,564  
Increase in valuation allowance     (43,576 )     (2,564 )
Net deferred tax asset   $ -     $ -  

 

The Company did not pay any income taxes during the years ended December 31, 2017 or 2016.

 

  6. Subsequent events

 

In accordance with FASB standard, we evaluated subsequent events through the date we filed this report with the Securities and Exchange Commission (“SEC”) and no subsequent events occurred that required disclosure in the accompanying consolidated financial statements except the following:

 

Consummation of SEA

 

On January 15, 2018, all parties to the SEA agreed to amend the original agreement and consummate the transaction forthwith. Shareholders of PBG Water solutions took control of Yakun International on the same date, and completed the Yakun International’s registry of new officers and directors as of the issuance of this financial statement.

 

Credit Loan Agreement

 

On May 1, 2018, the Company and Yakun International, the Company’s parent company after the consummation of SEA, entered into a Credit Loan Agreement with a 20.8% shareholder of Yakun who was the Company’s 25% shareholder before the SEA consummation (the “Lender”). The Lender had provided operation capital to the Company since its inception. Pursuant to the Credit Loan Agreement, the Lender will provide a loan credit sum of $500,000 to Yakun and the Company for 2 years with 10% annual interest which shall be applied from the date of the Credit Loan Agreement. In compensation for the loan credit, Yakun shall issue to the Lender a 3-year cash-less warrant, which entitles the Lender to purchase 50 million (50,000,000) shares of Yakun’s common stock at an exercise price of $0.01. The warrants cannot be exercised before April 1, 2019, and shall be void and non-exercisable if the Company (i) raises more than $20 million in equity or (ii) has revenue in excess of $100 million in any fiscal year.

 

Financial Advisory Agreement

 

In February 2018, the Company entered into a financial advisory agreement with Pluris Capital Group (the “Pluris”), an entity affiliated with Dragon & Tiger Holding Limited, pursuant to which the Company will pay Pluris $30,000 per quarter. The agreement has a term of five years from March 2018 but is cancellable by either party on sixty days’ notice. The service fee for the first 3 months is waived by Pluris.

 

 

F-11

 

Exhibit 2.1

 

SHARE EXCHANGE AGREEMENT

 

THIS SHARE EXCHANGE AGREEMENT (hereinafter referred to as this “ Agreement ”) is entered into as of this __ day of November, 2017, by and among Yakun International Investment & Holding Group. a Nevada corporation (“ Yakun ”), PBG Water Solutions International Inc., a Nevada corporation (the “Company”), and the stockholders of the Company (the “ Stockholders ”).

 

Preliminary Statement

 

Yakun desires to acquire 100% of the issued and outstanding shares of the Company from the Stockholders in exchange for the issuance of an aggregate of 46,839,439 shares of the common stock of the Company and 19,000 shares of the Series A Convertible Preferred Stock of the Company (together, the “ Exchange Shares ”), and the Stockholders are willing to exchange their shares of the Company (the “Company Shares”) in exchange for the Exchange Shares on the terms and subject to the conditions set forth herein (the “ Exchange ”). Upon consummation of the Exchange, the Company will become a wholly-owned subsidiary of Yakun.

 

The boards of directors of the Yakun and the Company have determined, subject to the terms and conditions set forth in this Agreement, that the transaction contemplated hereby is desirable and in the best interests of their respective stockholders. This Agreement is being entered into for the purpose of setting forth the terms and conditions of the proposed acquisition.

 

NOW THEREFORE , on the stated premises and for and in consideration of the mutual covenants and agreements hereinafter set forth and the mutual benefits to the parties to be derived here from, and intending to be legally bound hereby, it is hereby agreed as follows:

 

ARTICLE I

REPRESENTATIONS, COVENANTS, AND WARRANTIES OF THE COMPANY

 

As an inducement to, and to obtain the reliance of Yakun, except as set forth in the Company Schedules (as defined in Section 1.11 below) annexed hereto, the Company represents and warrants as follows:

 

Section 1.01 Incorporation . The Company is a corporation duly incorporated, validly existing, and in good standing under the laws of the State of Nevada and has the corporate power and is duly authorized under all applicable laws, regulations, ordinances, and orders of public authorities to carry on its business in all material respects as it is now being conducted. The Company has delivered to Yakun or its representatives complete and correct copies of the Articles of Incorporation and By-laws of the Company, each as in effect on the date hereof (the “ Company Charter Documents ”). The execution and delivery of this Agreement does not, and the consummation of the transactions contemplated hereby will not, violate any provision of the Company’s Charter Documents. The Company has taken all actions required by law, the Company Charter Documents, or otherwise to authorize the execution and delivery of this Agreement. The Company has full power, authority, and legal capacity and has taken all action required by law, the Company Charter Documents, and otherwise to consummate the transactions herein contemplated.

 

Section 1.02 Subsidiaries . The Company does have any subsidiaries and does not own, beneficially or of record, any shares of or control any other corporation, or equity interests in any other entity.

 

Section 1.03 Approval of Agreement . The Board of Directors of the Company has authorized the execution and delivery of this Agreement by the Company and the transactions contemplated hereby, and has recommended to the Stockholders that the Exchange be accepted.

 

Section 1.04 Valid Obligation . This Agreement and all agreements and other documents executed by the Company in connection herewith constitute the valid and binding obligation the Company, enforceable in accordance with its or their terms, except as may be limited by bankruptcy, insolvency, moratorium or other similar laws affecting the enforcement of creditors’ rights generally and subject to the qualification that the availability of equitable remedies is subject to the discretion of the court before which any proceeding therefore may be brought.

 

 

 

Section 1.05 No Conflict With Other Instruments . The execution of this Agreement and the consummation of the transactions contemplated by this Agreement will not result in the breach of any term or provision of, constitute a default under, or terminate, accelerate or modify the terms of, any indenture, mortgage, deed of trust, or other material agreement or instrument to which the Company is a party or to which any of its assets, properties or operations are subject.

 

Section 1.06 Capitalization . As of the date hereof, the authorized capital of the Company consists of 100,000,000 shares of common stock, of which 100 shares have been issued and are outstanding, all of which are owned by the Stockholders, and 10,000,000 shares of preferred stock, undesignated as to series, none of which have been issued or are outstanding. The issued and outstanding shares of common stock are validly issued, fully paid, and non-assessable and were not issued in violation of the preemptive or other rights of any person. There are no existing options, warrants, calls, or commitments of any character relating to the authorized and unissued stock of the Company.

 

Section 1.07 Compliance With Laws and Regulations . The Company has complied with all applicable statutes and regulations of any federal, state, or other applicable governmental entity or agency thereof, except to the extent that noncompliance would not materially and adversely affect its business, operations, properties, assets, or condition, except to the extent that noncompliance would not result in the occurrence of any material liability.

 

Section 1.08 Liabilities .

 

(a) The Company has no material liabilities, direct or indirect, matured or unmatured, contingent or otherwise, other than those set forth on Schedule 1.08(a) of the Company Schedules.

 

(b) Except as set forth in Schedule 1.08(b) of the Company Schedules, the Company has duly and punctually paid all governmental fees and taxes which it has become liable to pay and has duly allowed for all taxes reasonably foreseeable and is under no liability to pay any penalty or interest in connection with any claim for governmental fees or taxation and the Company has made any and all proper declarations and returns for taxation purposes and all information contained in such declarations and returns is true and complete and full provision or reserves have been made in its financial statements for all governmental fees and taxation.

 

Section 1.09 Litigation and Proceedings . There are no actions, suits, proceedings, or investigations pending or, to the knowledge of the Company after reasonable investigation, threatened by or against itor affecting it or its properties, at law or in equity, before any court or other governmental agency or instrumentality, domestic or foreign, or before any arbitrator of any kind. The Company is not in default of any judgment, order, injunction, decree, award, rule, or regulation of any court, arbitrator, or governmental agency or instrumentality. The Company is not a party to or bound by, and none of its properties is subject to, any judgment, order, writ, injunction, decree, or award.

 

Section 1.10 Books and Records . The books and records, financial and otherwise, of the Company are in all material aspects complete and correct and have been maintained in accordance with generally accepted accounting principles consistently applied throughout the periods involved.

 

Section 1.11 Company Disclosure Schedules . The Company has delivered to Yakun a schedule of any exceptions to the representations made herein (the “ Company Schedules ”), certified by the chief executive officer of the Company as complete, true, and correct as of the date of this Agreement in all material respects. The Company shall cause the Company Schedules and the instruments and data delivered to Yakun hereunder to be promptly updated after the date hereof up to and including the Closing Date.

 

Section 1.12 Information . The information concerning the Company set forth in this Agreement and in the Company Schedules is complete and accurate in all material respects and does not contain any untrue statement of a material fact or omit to state a material fact required to make the statements made, in light of the circumstances under which they were made, not misleading.

 

2

 

 

ARTICLE II

 

REPRESENTATIONS AND WARRANTIES OF THE STOCKHOLDERS

 

Each of the Stockholders, severally but not jointly, hereby represents and warrants to Yakun as follows.

 

Section 2.01 Good Title . The Stockholder is the record and beneficial owner, and has good title to the shares of common stock of the Company owned by such Stockholder and listed on Table I annexed hereto (the “ Company Shares ”), with the right and authority to sell and deliver such Company Shares, free and clear of all liens, claims, charges, encumbrances, pledges, mortgages, security interests, options, rights to acquire, proxies, voting trusts or similar agreements, restrictions on transfer or adverse claims of any nature whatsoever. Upon delivery of any certificate or certificates duly assigned, representing the same as herein contemplated and/or upon registering of Yakun as the new owner of such Company Shares in the share register of the Company, Yakun will receive good title to such Company Shares, free and clear of all liens.

 

Section 2.02 Power and Authority . Such Stockholder has the legal power, capacity and authority to execute and deliver this Agreement to consummate the transactions contemplated by this Agreement, and to perform such Stockholder’s obligations under this Agreement. This Agreement constitutes a legal, valid and binding obligation of the Stockholder, enforceable against the Stockholder in accordance with the terms hereof.

 

Section 2.03 No Conflicts . The execution and delivery of this Agreement by such Stockholder and the performance by such Stockholder of his or its obligations hereunder in accordance with the terms hereof: (a) will not require the consent of any third party or governmental entity under any laws; (b) will not violate any laws applicable to such Stockholder and (c) will not violate or breach any contractual obligation to which such Stockholder is a party.

 

Section 2.04 Acquisition of Exchange Shares for Investment .

 

(a) The Stockholder is acquiring the Exchange Shares for investment for such Stockholder’s own account and not as a nominee or agent, and not with a view to the resale or distribution of any part thereof, and such Stockholder has no present intention of selling, granting any participation in, or otherwise distributing the same. He further represents he does not have any contract, undertaking, agreement or arrangement with any person to sell, transfer or grant participation to such person or to any third person, with respect to any of the Exchange Shares.

 

(b) The Stockholder represents and warrants that Such Stockholder (i) can bear the economic risk of such Stockholder’s investment in the Exchange Shares, and (ii) possesses such knowledge and experience in financial and business matters that heis capable of evaluating the merits and risks of the investment in Yakun and its securities.

 

(c) The Stockholder understands that the Exchange Shares are being offered and sold in reliance on an exemption from the registration requirements of the Securities Act under either (x) Rule 506 of Regulation D promulgated under the Securities Act (“Regulation D”) and as “covered securities” (as defined in Section 18(b)(4XE) of the Securities Act for purposes of state securities laws, based upon the representations and warranties of the Stockholder set forth below that the Stockholder is an “accredited investor,” as such term is defined in Rule 501 of Regulation D (“Accredited Investor”), or (y) Regulation S promulgated under the Securities Act (“Regulation S”), based upon the representations and warranties of the Stockholder as set forth below that the Stockholder is not a “U.S. Person,” as defined in Rule 902(k) of Regulation S and that the issuance and sale of the Exchange Shares occurred in an “off-shore transaction,” as defined in Rule 902 (h) of Regulation S, and that in either case the Company is relying upon the truth and accuracy of the representations, warranties, agreements, acknowledgments and understandings of the Stockholder set forth herein in order to determine the applicability of such exemptions and the suitability of the Investor to acquire the Exchange Shares. In this regard, the Stockholder represents, warrants and agrees that either:

 

(1) The Stockholder is an “accredited investor”, as such term is defined in Rule 501(a) of Regulation D.; or

 

(2) The Stockholder is not a “U.S. Person” as defined in Rule 902(k) of Regulation S of the Securities Act (“Regulation S”) and understands that the Exchange Shares are not registered under the Securities Act and that the issuance thereof to such Shareholder is intended to be exempt from registration under the Securities Act pursuant to Regulation S. The Stockholder has no intention of becoming a U.S. Person, and at the time of the origination of contact concerning this Agreement and the date of the execution and delivery of this Agreement, the Stockholder was outside of the United States.

 

3

 

 

Stockholder understands and acknowledges that each certificate representing the Exchange Shares shall be endorsed with the following legends, in addition to any other legend required to be placed thereon by applicable federal or state securities laws:

 

If the Stockholder is an “accredited investor”:

 

“THE SECURITIES EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (“THE SECURITIES ACT”), IN RELIANCE UPON THE EXEMPTION FROM REGISTRATION PROVIDED BY RULE 506 OF REGULATION D OF THE SECURITIES ACT AND THE REPRESENTATIONS OF THE INVESTOR SET FORTH IN THE INVESTOR’S SUBSCRIPTION AGREEMENT WITH THE COMPANY, INCLUDING THE INVESTOR’S REPRESENTATION THAT THE INVESTOR IS AN ACCREDITED INVESTOR (AS DEFINED IN RULE 501 OF REGULATION D) AND THAT THE INVESTOR ACQUIRED THE SECURITIES FOR INVESTMENT PURPOSES ONLY AND NOT WITH A VIEW TO RESALE OR FURTHER DISTRIBUTION IN VIOLATION OF APPLICABLE LAW.

 

THE SECURITIES EVIDENCED BY THIS CERTIFICATE MAY NOT BE OFFERED FOR SALE, SOLD, DELIVERED AFTER SALE, HYPOTHECATED, NOR WILL ANY ASSIGNEE OR ENDORSEE HEREOF BE RECOGNIZED AS AN OWNER HEREOF BY THE ISSUER FOR ANY PURPOSE, UNLESS A REGISTRATION STATEMENT FILED WITH THE SECURITIES AND EXCHANGE COMMISSION WITH RESPECT TO THE SECURITIES EVIDENCED BY THIS CERTIFICATE SHALL THEN BE IN EFFECT OR UNLESS THE AVAILABILITY OF AN EXEMPTION FROM REGISTRATION SHALL BE ESTABLISHED TO THE REASONABLE SATISFACTION OF COUNSEL OF THE ISSUER.”

 

If the Stockholder is not a “U.S. Person”:

 

“THE SECURITIES EVIDENCED BY THIS CERTIFICATE HAVE BEEN OFFERED TO INVESTORS WHO ARE NOT U.S. PERSONS (AS DEFINED IN REGULATION S UNDER THE SECURITIES ACT OF 1933, AS AMENDED (“SECURITIES ACT”)) AND WITHOUT REGISTRATION WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION UNDER THE SECURITIES ACT IN RELIANCE UPON REGULATION S PROMULGATED UNDER THE SECURITIES ACT.”

 

“TRANSFER OF THESE SECURITIES IS PROHIBITED, EXCEPT IN ACCORDANCE WITH THE PROVISIONS OF REGULATION S, PURSUANT TO REGISTRATION UNDER THE SECURITIES ACT, OR PURSUANT TO AVAILABLE EXEMPTION FROM REGISTRATION. HEDGING TRANSACTIONS MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH THE SECURITIES ACT.”

 

(d) The Stockholder acknowledges that neither the SEC, nor the securities regulatory body of any state or other jurisdiction, has received, considered or passed upon the accuracy or adequacy of the information and representations made in this Agreement.

 

(e) The Stockholder acknowledges that such Stockholder has carefully reviewed such information as such Stockholder has deemed necessary to evaluate an investment in Yakun and its securities. To such Stockholder’s full satisfaction, such Stockholder has been furnished all materials that such Stockholder has requested relating to Yakun and the issuance of the Exchange Shares hereunder, and such Stockholder has been afforded the opportunity to ask questions of Yakun’s representatives to obtain any information necessary to verify the accuracy of any representations or information made or given to the Stockholder. Notwithstanding the foregoing, nothing herein shall derogate from or otherwise modify the representations and warranties of Yakun set forth in this Agreement, on which the Stockholder has relied in making an exchange of such Stockholder’s Company Shares for the Exchange Shares.

 

(f) The Stockholder understands that the Exchange Shares may not be sold, transferred, or otherwise disposed of without registration under the Securities Act or an exemption therefrom, and that in the absence of an effective registration statement covering the Exchange Shares or any available exemption from registration under the Securities Act, the Exchange Shares may have to be held indefinitely.

 

4

 

 

(g) The Stockholder agrees that, notwithstanding anything contained herein to the contrary, the warranties, representations, agreements and covenants of the Stockholder under this Section 2.05 shall survive the Closing for the period set forth in Section 6.11.

 

Section 2.05 Additional Legends: Consent . The Stockholder consents to Yakun making a notation on its records or giving instructions to any transfer agent of Exchange Shares in order to implement the restrictions on transfer of the Exchange Shares.

 

Section 2.06 Finder’s Fee . Such Stockholder has not created any obligation for any finder’s, investment banker’s or broker’s fee in connection with the Exchange.

 

ARTICLE III

REPRESENTATIONS, COVENANTS, AND WARRANTIES OF YAKUN

 

As an inducement to, and to obtain the reliance of the Company and the Stockholders, except as set forth in the Yakun Schedules (as such term is hereinafter defined), Yakun represents and warrants as follows:

 

Section 3.01 Incorporation . Yakun is a corporation duly incorporated, validly existing, and in good standing under the laws of the State of Nevada and has the corporate power and is duly authorized under all applicable laws, regulations, ordinances, and orders of public authorities to carry on its business in all material respects as it is now being conducted. Yakun has made available to the Company and the Stockholders complete and correct copies of Yakun’s Articles of Incorporation (including the Certificate of Designation authorizing the issuance of its Series A Convertible Preferred Stock) and By-laws, each as in effect on the date hereof (together, the “Yakun Charter Documents”). The execution and delivery of this Agreement does not, and the consummation of the transactions contemplated hereby will not, violate any provision of Yakun’s Charter Documents. Yakun has taken all action required by law, the Yakun Charter Documents, or otherwise to authorize the execution and delivery of this Agreement, and Yakun has full power, authority, and legal right and has taken all action required by law, the Yakun Charter Documents, or otherwise to consummate the transactions herein contemplated.

 

Section 3.02 Subsidiaries . Yakun does not have any subsidiaries, and does not own, beneficially or of record, any shares of any other corporation or equity interests in any other entity.

 

Section 3.03 Approval of Agreement . The Board of Directors Yakun has authorized the execution and delivery of this Agreement by Yakun and has approved this Agreement and the transactions contemplated hereby.

 

Section 3.04 Valid Obligation . This Agreement and all agreements and other documents executed by Acquirer in connection herewith constitute the valid and binding obligation of Yakun, enforceable in accordance with its or their terms, except as may be limited by bankruptcy, insolvency, moratorium or other similar laws affecting the enforcement of creditors’ rights generally and subject to the qualification that the availability of equitable remedies is subject to the discretion of the court before which any proceeding therefore may be brought.

 

Section 3.05 No Conflict With Other Instruments . The execution of this Agreement and the consummation of the transactions contemplated by this Agreement will not result in the breach of any term or provision of, constitute a default under, or terminate, accelerate or modify the terms of, any indenture, mortgage, deed of trust, or other material agreement or instrument to which Yakun is a party or to which any of its assets, properties or operations are subject.

 

5

 

 

Section 3.06 Capitalization .

 

(a) The authorized capital stock of Yakun consists of 70,000,000 shares of common stock (the “Yakun Common Stock”), of which 13,259,600shares have been issued and are outstanding, and 5,000,000 shares of preferred stock, of which 20,000 shares are designated as Series A Convertible Preferred Stock. Each share of Series A Convertible Preferred Stock is convertible into 1,000 shares of Yakun Common Stock. Since there are not sufficient authorized but unissued shares of Yakun Common Stock for the conversion of all of the outstanding shares of Series A Convertible Preferred Stock, the shares of Series A Convertible Preferred Stock may not be converted until Yakun files a Certificate of Amendment to its Articles of Incorporation with the Secretary of State of Nevada increasing the number of authorized shares of Yakun Common Stock sufficient for the conversion of all of the outstanding shares of Series A Convertible Preferred Stock (the “Yakun Charter Amendment”). All of the issued and outstanding shares of Yakun Common Stock are legally issued, fully paid, and non-assessable and not issued in violation of the preemptive or other rights of any person. No shares of Yakun Common Stock are reserved for issuance upon the exercise of outstanding warrants to purchase shares of Yakun Common Stock; and no shares Yakun Common Stock are reserved for issuance upon the conversion of any outstanding convertible notes, debentures or other securities. All shares of Yakun Common Stock have been issued and granted in compliance with (i) all applicable securities laws and (in all material respects) other applicable laws and regulations, and (ii) all requirements set forth in any applicable agreements. There are no existing options, warrants, calls, or commitments of any character relating to the authorized and unissued stock of Yakun.

 

(b) Except for the outstanding shares of Yakun Common Stock, there are no equity securities, partnership interests or similar ownership interests of any class of any equity security of Yakun, or any securities exchangeable or convertible into or exercisable for such equity securities, partnership interests or similar ownership interests, issued, reserved for issuance or outstanding. There are no subscriptions, options, warrants, equity securities, partnership interests or similar ownership interests, calls, rights (including preemptive rights), commitments or agreements of any character to which Yakun is a party or by which it is bound obligating Yakun to issue, deliver or sell, or cause to be issued, delivered or sold, or repurchase, redeem or otherwise acquire, or cause the repurchase, redemption or acquisition of, any shares of capital stock, partnership interests or similar ownership interests of Yakun or obligating Yakun to grant, extend, accelerate the vesting of or enter into any such subscription, option, warrant, equity security, call, right, commitment or agreement. There is no plan or arrangement to issue shares of Yakun Common Stock or Series A Convertible Preferred Stock, except as set forth in this Agreement.

 

There are no registration rights, and there is no voting trust, proxy, rights plan, anti-takeover plan or other agreement or understanding to which Yakun is a party or by which it is bound with respect to any equity security of any class of Yakun, and there are no agreements to which Yakun is a party, or of which Yakun has knowledge, which conflict with this Agreement or the transactions contemplated herein or otherwise prohibit the consummation of the transactions contemplated hereunder.

 

Section 3.07 Liabilities .

 

(a) Yakun has no material liabilities, direct or indirect, matured or unmatured, contingent or otherwise, other than those set forth on Schedule 3.07 of the Yakun Schedules.

 

(b) Except as set forth in Schedule 3.07(b) of the Yakun Schedules, Yakun has duly and punctually paid all governmental fees and taxes which it has become liable to pay and has duly allowed for all taxes reasonably foreseeable and is under no liability to pay any penalty or interest in connection with any claim for governmental fees or taxation and the Company has made any and all proper declarations and returns for taxation purposes and all information contained in such declarations and returns is true and complete and full provision or reserves have been made in its financial statements for all governmental fees and taxation.

 

Section 3.08 Compliance With Laws and Regulations . Yakun has complied with all applicable statutes and regulations of any national, provincial, municipal or other applicable governmental entity or agency thereof.

 

Section 3.09 Litigation and Proceedings . There are no actions, suits, proceedings or investigations pending or, to the knowledge of Yakun, threatened against Yakun, or affecting Yakun or its properties, at law or in equity, before any court or other governmental agency or instrumentality, domestic or foreign, or before any arbitrator of any kind, except as disclosed in Schedule 3.08 of the yakun Schedules . Yakun is not in default with respect to any judgment, order, writ, injunction, decree, award, rule or regulation of any court, arbitrator, or governmental agency or instrumentality.

 

Section 3.10 Books and Records . The books and records, financial and otherwise, of Yakun are in all material aspects complete and correct and have been maintained in accordance with generally accepted accounting principles consistently applied throughout the periods involved.

 

6

 

 

Section 3.11 Yakun Schedules . Yakun has delivered to the Company and the Stockholders the following schedules, which are collectively referred to as the “ Yakun Schedules ” and which consist of separate schedules, which are dated the date of this Agreement, all certified by the chief executive officer of Yakun to be complete, true, and accurate in all material respects as of the date of this Agreement.

 

(a) a schedule of any exceptions to the representations made herein; and

 

(e) a schedule containing the other information requested herein.

 

Yakun shall cause the Yakun Schedules and the instruments and data delivered to the Company and the Stockholders hereunder to be promptly updated after the date hereof up to and including the Closing Date.

 

Section 3.12 Information . The information concerning Yakun set forth in this Agreement and in the Yakun Schedules is complete and accurate in all material respects and does not contain any untrue statement of a material fact or omit to state a material fact required to make the statements made, in light of the circumstances under which they were made, not misleading.

 

ARTICLE IV

PLAN OF EXCHANGE

 

Section 4.01 The Exchange . On the terms and subject to the conditions set forth in this Agreement, the Stockholders by executing this Agreement, shall assign, transfer and deliver, free and clear of all liens, pledges, encumbrances, charges, restrictions or known claims of any kind, nature, or description, the Company Shares, constituting all of the outstanding shares of the Company. In exchange for the transfer of the Company Shares by the Stockholders, Yakun shall issue to the Stockholders or their respective assigns the Exchange Shares allocated amongst them in the manner set forth on the Table I annexed hereto. The Stockholders shall, on surrender of the certificate or certificates representing the Company Shares to Yakun or its registrar or transfer agent, be entitled to receive a certificate or certificates evidencing the number and class or series of Exchange Shares set opposite their respective names on the Tablet annexed hereto.

 

Upon consummation of the Exchange, all of the issued and outstanding shares of the Company shall be held by Yakun.

 

Section 4.02 Closing . The closing (the “ Closing ” or the “ Closing Date ”) of the transactions contemplated by this Agreement shall occur contemporaneously with the execution of this Agreement upon the exchange of the shares of the Company and the Exchange Shares as described in Section 4.01 herein.

 

Section 4.03 Closing Events . At the Closing, or as soon as reasonably practicable thereafter, Yakun, the Company and the Stockholders shall execute, acknowledge, and deliver (or shall ensure to be executed, acknowledged, and delivered), any and all certificates, opinions, financial statements, schedules, agreements, resolutions, rulings or other instruments required by this Agreement to be so delivered at or prior to the Closing, together with such other items as may be reasonably requested by the parties hereto and their respective legal counsel in order to effectuate or evidence the transactions contemplated hereby.

 

ARTICLE V

SPECIAL COVENANTS

 

Section 5.01 Delivery of Books and Records . At the Closing, the Company shall deliver to Yakun the originals of the corporate minute books, books of account, contracts, records, and all other books or documents of the Company which is now in the possession of the Company or its representatives.

 

Section 5.02 Third Party Consents and Certificates . Yakun and the Company agree to cooperate with each other in order to obtain any required third party consents to this Agreement and the transactions herein contemplated.

 

7

 

 

Section 5.03 Amendment to Articles of Incorporation of Yakun Increasing the Number of Authorized Shares of Common Stock . Yakun will file the Yakun Charter Amendment with the Secretary of State of the State of Nevada within 30 days after the Closing and will promptly thereafter issue to the Stockholder receiving shares of Series A Convertible Preferred Stock as part of the Exchange Shares the certificates evidencing the shares of Yakun Common Stock issuable upon conversion of such shares of Series A Convertible Preferred Stock.

 

Section 5.04 Indemnification .

 

(a) The Company hereby agrees to indemnify Yakun and each of the officers, agents and directors of Yakun as of the date of execution of this Agreement against any loss, liability, claim, damage, or expense (including, but not limited to, any and all expense whatsoever reasonably incurred in investigating, preparing, or defending against any litigation, commenced or threatened, or any claim whatsoever) (the “ Loss ”), to which it or they may become subject arising out of or based on any inaccuracy appearing in or misrepresentations made under Article I of this Agreement. The indemnification provided for in this paragraph shall survive the Closing and consummation of the transactions contemplated hereby and termination of this Agreement for one year following the Closing.

 

(b) Each of the Stockholders agrees, severally but not jointly, to indemnify Yakun and each of the officers, agents and directors of Yakun as of the date of execution of this Agreement against any Loss, to which such Stockholder or they may become subject arising out of or based on any inaccuracy appearing in or misrepresentations made under Article II of this Agreement. The indemnification provided for in this paragraph shall survive the Closing and consummation of the transactions contemplated hereby and termination of this Agreement for one year following the Closing.

 

Section 5.05 The Acquisition of Exchange Shares . In connection with the transaction contemplated by this Agreement, Yakun and the Company shall each file, with the assistance of the other and their respective legal counsel, such notices, applications, reports, or other instruments as may be deemed by them to be necessary or appropriate in an effort to document reliance on such exemptions, all to the extent and in the manner as may be deemed by such parties to be appropriate.

 

ARTICLE VI

MISCELLANEOUS

 

Section 6.01 Brokers . Yakun and the Company agree that, except as set out on Schedule 6.01 attached hereto, there were no finders or brokers involved in bringing the parties together or who were instrumental in the negotiation, execution or consummation of this Agreement. Yakun and the Company agree to indemnify the other against any claim by any third person other than those described above for any commission, brokerage, or finder’s fee arising from the transactions contemplated hereby based on any alleged agreement or understanding between the indemnifying party and such third person, whether express or implied from the actions of the indemnifying party.

 

Section 6.02 Governing Law . This Agreement shall be governed by, enforced, and construed under and in accordance with the laws of the State of New York, except that matters relating to the ownership and internal affairs of the company shall be construed and interpreted in accordance with the laws of the State of Nevada applicable to corporate entities.

 

Section 6.03 Notices . Any notice or other communications required or permitted hereunder shall be in writing and shall be sufficiently given if personally delivered to it or sent by telecopy, overnight courier or registered mail or certified mail, postage prepaid, addressed to the recipient at such address as it has provided to the other parties hereto at the time of execution of this Agreement or such other addresses as shall be furnished in writing by any party in the manner for giving notices hereunder, and any such notice or communication shall be deemed to have been given (i) upon receipt, if personally delivered, (ii) on the day after dispatch, if sent by overnight courier, (iii) upon dispatch, if transmitted by telecopy and receipt is confirmed by telephone and (iv) three (3) days after mailing, if sent by registered or certified mail.

 

8

 

 

Section 6.04 Attorney’s Fees . In the event that either party institutes any action or suit to enforce this Agreement or to secure relief from any default hereunder or breach hereof, the prevailing party shall be reimbursed by the losing party for all costs, including reasonable attorney’s fees, incurred in connection therewith and in enforcing or collecting any judgment rendered therein.

 

Section 6.05 Schedules: Knowledge . Each party is presumed to have full knowledge of all information set forth in the other party’s schedules delivered pursuant to this Agreement.

 

Section 6.06 Third Party Beneficiaries . This agreement is strictly between Yakun and the Company, and, except as specifically provided, no director, officer, stockholder (other than the Stockholders), employee, agent, independent contractor or any other person or entity shall be deemed to be a third party beneficiary of this Agreement.

 

Section 6.07 Expenses . Each of Yakun and the Company will bear their own respective expenses, including legal, accounting and professional fees, incurred in connection with the Exchange or any of the other transactions contemplated hereby.

 

Section 6.08 Entire Agreement . This Agreement represents the entire agreement between the parties relating to the subject matter thereof and supersedes all prior agreements, understandings and negotiations, written or oral, with respect to such subject matter.

 

Section 6.09 Survival: Termination . The representations, warranties, and covenants of the respective parties shall survive the Closing Date and the consummation of the transactions herein contemplated for a period of one year.

 

Section 6.10 Counterparts . This Agreement may be executed in multiple counterparts, each of which shall be deemed an original and all of which taken together shall be but a single instrument.

 

Section 6.11 Amendment or Waiver . Every right and remedy provided herein shall be cumulative with every other right and remedy, whether conferred herein, at law, or in equity, and may be enforced concurrently herewith, and no waiver by any party of the performance of any obligation by the other shall be construed as a waiver of the same or any other default then, theretofore, or thereafter occurring or existing.

 

[Signature Pages Follow]

 

9

 

 

IN WITNESS WHEREOF, the corporate parties hereto have caused this Agreement to be executed by their respective officers, hereunto duly authorized, as of the date first-above written.

 

Yakun International Investment & Holding Group
     
By:              
Name:    
  President and Chief Executive Officer  
     
PBG Water Solutions International Inc.  
     
By: /s/ Mao Xu  
Name: Mao Xu  
  President and Chief Executive Officer  

 

Accepted And Approved by the Stockholders:  
     
/s/ Mao Xu    
Mao Xu    
     
/s/ Yu Tao    
Yu Tao    

 

Dragon &Tiger Holding Limited  
     
By:               
  SonggeTeng  
  Manager  

 

10

 

 

Table I

 

Exchange Shares to be Issued

 

Name of Stockholder   Number of Exchange Shares     Company Shares  
    Common     Series A Preferred     Number     Percent  
                         
Mao Xu   32,919,719         50     50 %
Yu Tao     459,860       16,000       25       25 %
Dragon & Tiger Holding Limited     13,459,860       3,000       25       25 %
      46,839,439       19,000       100       100.0 %

 

11

 

 

Share Exchange Agreement  

PBG Water Solutions International Inc. Schedules

Exceptions to Representations

 

 

 

 

12

 

 

Share Exchange Agreement

Yakun International Investment Holding Group

Exceptions to Representations

 

 

 

13

 

 

 

Exhibit 10.1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exhibit 10.2

 

AMENDMENT TO LICENSE AND SUPPLY AGREEMENT

 

License and Requirements Supply Agreement (“the Original Agreement”) was made on April 3 rd , 2017 between PBG Water Solutions International Inc. ("PBG" or - Licensee"), on the one hand, and Beijing QHY Environment S & T Co., Ltd (北京清泓源环境科学技术有限公司) and Mr. Mao Xu (毛旭) (the "Licensor" or - Supplier"), on the other hand, pursuant to which Licensor granted PBG an exclusive license to commercialize and develop certain methods, products and supportive equipment on an exclusive basis in the Designated Markets (as hereinafter defined) on the terms and subject to the conditions set forth in the Original Agreement.

 

The parties desire to amend selected terms and conditions of the Original Agreement in the manner set forth herein. Except as specifically amended below, the Original Agreement remains in full force and effect.

 

This Amendment To License and Supply Agreement was made as of June 22 nd , 2017

 

ARTICLE I

 

1.10 “License Year” shall mean each fiscal year during the term of this Agreement commencing July 1 of that calendar year and ending June 30 of the following calendar year.

  

1.11 “Net Revenues” means amounts actually received by PBG from the sale, license or other distribution of Licensed Products in the Designated Markets for each License Year during the Term, net of (i) cash discounts, coupons, or rebates actually allowed or granted; (ii) credits or allowances actually granted upon claims or returns; (iii) freight, loading and similar charges paid for delivery; and (iv) taxes or other governmental charges levied on or measured by the amount invoiced by PBG.

 

1.12 “Quarter” shall mean each calendar quarter during the Term, commencing July 1, 2018.

  

ARTICLE 2

 

2.02 License Fee . (a) In consideration for the exclusive and irrevocable license granted hereby, PBG shall pay to Licensor, a one-time license fee of USD one million ($1,000,000), no later than December 31, 202. During the Term, PBG shall pay Licensor a royalty fee equal to one per cent (1%) of PBG’s Net Revenues. The royaly fee accrued during any fiscal year of Licensee shall be paid in ninety (90) days after the fiscal year end.

 

ARTICLE 8

 

8.01 Term . The term of this Agreement shall commence as of April 3, 2017 and, unless terminated at an earlier date in accordance with the terms of this Agreement, shall continue until the later of June 30, 2037 (the “Initial Term”) and the date upon which the last of the Licensed Patents expire (the “Initial Term”); provided that the term of this Agreement shall be automatically extended for additional successive one year terms thereafter (each, a “Renewal Term”), unless not less ninety (90) days prior to the end of the Initial Term or any Renewal Term Licensor or PBG shall have given written notice of termination to the other party, which notice shall specify the date of termination.

   

 

 

 

ARTICLE 10 LICENSE FEE REPORTS AND LICENSOR’S RIGHT OF INSPECTION

 

10.01 Reports . Within ninety (90) days after the end of the fiscal year, Licensee shall furnish or cause to be furnished to Licensor a written report showing: (i) Net Revenues of all Licensed Products during such License Year; and (ii) the License Fee payable to Licensor for that year, which report shall be accompanied by the payment of the License Fee payable for such year;

  

10.02 Licensor’s Right of Inspection . Licensor shall have the right, at its own expense, to have an independent accountant to whom PBG has no reasonable objection, examine the relevant books and records of account of PBG during normal business hours and no more than once during each License Year, to verify the accuracy of the reports and to determine whether appropriate payment has been made by PBG hereunder. PBG shall include in each sublicense granted by it pursuant hereto a provision requiring the Affiliate sublicensee to keep and maintain records of sales made pursuant to such sublicense, and to grant access to such records to Licensor. If the report of Licensor’s independent accountant shows an underpayment of royalties, PBG shall remit to Licensor the amount of such underpayment, together with interest on the amount of such underpayment at the rate of 6% per annum, within thirty (30) days after Licensor’s receipt of such report. If the report of Licensor’s independent accountant shows an underpayment of more than five percent (5%) of the amounts due during the period covered thereby, PBG shall pay Licensor's reasonable fees and expenses related to such audit.

 

10.03 Payments on Sales outside the United States . Except as otherwise provided, any payments due hereunder on sales made by PBG outside the United States shall be payable to Licensor in United States Dollars at the prevailing rate of exchange of the currency of the country in which the sales are made (said exchange rate being taken as the rates published in the Wall Street Journal under the caption “Currency Trading —— Exchange Rates” on the last business day of the calendar Quarter for which the royalties are payable).

 

10.04 Withheld Payment . Any sum required under United States tax laws or the tax laws of any other country, to be withheld by PBG from payments for the account of Licensor, shall be promptly paid by PBG for and on behalf of Licensor to the appropriate tax authorities and PBG shall furnish Licensor with official tax receipts or other appropriate evidence issued by the appropriate tax authorities sufficient to enable Licensor to support a claim for income tax credit in respect of any sum so withheld.

 

10.05 Exchange Rate not Ascertainable . During any period in which the exchange rate between the foreign currency in question and the United States Dollar cannot be ascertained in accordance with this Article, payment of the applicable royalties shall be made at the last ascertainable rate; provided, however, that within thirty (30) days after the rate of exchange is ascertainable, an adjustment shall be made and Licensor, in its discretion, may elect to receive payment in the foreign currency in question or in any other currency for which an exchange rate can be ascertained. The above notwithstanding, if the payment by PBG to Licensor in United States Dollars or other currency is not permissible, such payment may be made by a deposit in the currency of the country where the Net Revenues were generated to the credit and account of Licensor in any commercial bank or trust company of PBG choice in that country; prompt notice of which shall be given to Licensor.

 

(Signatures appear on the following page)

  

 

 

  

Signatures page  
   
PBG WATER SOLUTIONS INTERNATIONAL INC.  
   
By: /s/ Roy Teng  
  Roy Teng, Vice President  
   
BEIJING QHY ENVIRONMENT S & T CO., LTD. 北京清泓源环境科学技术有限公司  
   
By: /s/ Mao Xu  
  Mao Xu, Director  
   
  /s/ Mao Xu  
  Mr. Mao Xu  

 

 

 

 

Exhibit 10.3

 

CREDIT LOAN AGREEMENT

 

THIS CREDIT LOAN AGREEMENT (hereinafter, “the Agreement” ) is entered into in New York, New York, the United States of America (the “USA”), as of May 1, 2018 by and between the following Parties:

 

Party A: Dragon & Tiger Holding Limited, a corporation organized and existing under the laws of Cayman Islands, having its business address at Cayman Islands (hereinafter referred to as the “ Lender ”).

 

Party B : PBG Water Solutions International Inc. , (the “ PBG ”) a corporation organized and existing under the laws of Nevada, USA, having its business address at New York, New York and Yakun International Investment and Holding Group (the “ Yakun ”), a corporation organized and existing under the laws of Nevada, USA, having its business address at New York, New York (hereinafter collectively referred to as the “ Borrower ”.)

 

(In this Agreement, the aforesaid parties are hereinafter referred to individually as a “Party ” and collectively as the “ Parties ”.)

 

WHEREAS,

 

A. Parties agree that Lender provides the loan to Borrower under this agreement.

 

B. In order to define the rights and obligations of the Borrower and the Lender under relevant loan arrangements, the Parties hereby agree as follows:

 

1. Definitions

 

1.1 In this Agreement:

 

“Debt” means the amount of loans which have not been repaid.

 

“Effective Date” means the date on which this Agreement is duly executed by the Parties hereto.

 

“USD” means United States Dollar

 

“Loan” means the loan in USD or equivalent amount of foreign currency provided by the Lender to the Borrower.

 

“Repayment Notice” has the meaning as provided in Article 5.

 

1.2 Any term referred to herein shall have the following meanings:

 

“Article” shall, unless the context otherwise requires, be construed as a reference to a clause of this Agreement.

 

“Tax” shall be construed so as to include any tax, levy, impost or other charge of a similar nature (including, without limitation, any penalty or interest payable in connection with any failure to pay or any delay in paying any of the same).

 

The “ Lender ” and the “ Borrower ” shall be construed so as to include their successors and assigns as permitted by the Parties based on their respective interests.

 

1.3 Unless otherwise provided, any reference herein to this Agreement or any other agreement or document shall be construed as including any amendments, variations, substitutions or supplements as are already made or may be from time to time made to this Agreement or such other agreement or document, as the case may be.

 

 

 

 

1.4 The headings are for reference only.

 

1.5 Unless the context otherwise requires, the words importing the plural shall include the singular and vice versa.

 

2. Credit of Loan

 

2.1 Party A agrees to provide the credit sum of USD500,000 or equivalent amount of foreign currency to Party B (“Agreed Credit Sum”), that is, Party B is entitled to require USD500,000 or equivalent amount of foreign currency from Party A. Party B has the right of applying Agreed Credit Sum.

 

2.2 As of the date of the Agreement, Party A has provided USD 198,730 loans, collectively, to Party B which shall be part of the credit sum.

 

2.3 Under the Agreed Credit Sum, An Annual Interest Rate of 10% will be applied on the actual amount Party B receives. Interest shall begin to accrue from the date of receipt of any advance, except that interest will begin to accrue from May 1, 2018, on the $198,730 already advanced. As additional compensation for the credit sum provided, Yakun shall issue to Party A a Three (3)-year cashless warrant, which entitles Party A to purchase 50 million (50,000,000) shares of Yakun’s common stock at an exercise price of $0.01 (the “Warrant”). The Warrant shall be issued in substantially the form attached hereto as Exhibit A. The Warrant shall be issued on the date of execution of the Agreement.

 

3. Use and Term of Loan

 

3.1 The term of the credit facility hereunder shall be Two (2) years, counted from the date of the Agreement.

 

3.2 The Borrower shall only use the Loan hereunder provided by the Lender for the payment of expenses needed for developing the Borrower’s business and the expenses for being a listed company. Without the prior written consent of the Lender, the Borrower shall not use any Loan for any purpose other than as specified herein.

 

3.3 The annual interest rate is 10% and shall be paid to the Lender in ninety (90) days after each fiscal year end of the Borrower.

 

4. Granting of the Loan

 

After receiving the written notice from the Borrower, the Lender shall transfer the loan within appropriate period but no more than thirty (30) days.

 

5. Repayment

 

The Borrower may at any time serve a repayment application (hereinafter, the “ Repayment Notice ”) thirty (30) days in advance to the Lender, notifying the repayment of the Debt in full or in part.

 

6. Taxes

 

All Taxes that may incur in connection with the Loan shall be borne by the Lender.

 

  2  

 

 

7. Confidentiality

 

7.1 Regardless of the termination of this Agreement, the Borrower shall be obliged to keep in confidence the following information (hereinafter collectively the “Confidential Information”):

 

(i) the execution, performance and the contents of this Agreement; and (ii) the business secret, proprietary information and customer information of the Lender known to or received by the Borrower in connection with the execution and performance of this Agreement. The Borrower is only entitled to use such Confidential Information for the performance of its obligations hereunder. The Borrower shall not disclose the above Confidential Information to any third party without the written permission of the Lender; otherwise it shall be liable to the default liability and indemnify the losses of the Lender.

 

7.2 Upon termination of this Agreement, the Borrower shall, upon request by the Lender, return, destroy or otherwise dispose of all the documents, materials or software containing the Confidential Information and cease to use such Confidential Information.

 

7.3 Notwithstanding any other provisions herein, the validity of this Article 7 shall survive the suspension or termination of this Agreement.

 

8. Notices

 

8.1 Any notice, request, demand and other correspondence required by or made in accordance with this Agreement shall be in writing and delivered to the relevant Party.

 

8.2 Any of the aforementioned notices or other correspondence shall be deemed to have been given upon delivery when it is transmitted by facsimile; or upon handover to the receiver when it is delivered in person, or on the fifth (5) day after posting when it is delivered by mail.

 

9. Defaulting Liabilities

 

9.1 The Borrower shall undertake to hold the Lender harmless and indemnify the Lender against any actions, charges, claims, costs, damages, demands, expenses, liabilities, losses and proceedings which the Lender may suffer or be subject to as a result of any default by the Borrower of its obligations hereunder.

 

9.2 Notwithstanding any other provisions herein, the validity of this Article shall survive the suspension or termination of this Agreement.

 

9.3 The guarantor shall undertake the joint liability for the performance of the Borrower.in this Agreement.

 

10. Miscellaneous

 

10.1 This Agreement shall be governed by, enforced, and construed under and in accordance with the laws of the United States of America and, with respect to the matters of state law, with the laws of the State of Nevada.  Venue for all matters shall be in New York, New York, without giving effect to principles of conflicts of law thereunder.  Each of the parties irrevocably consents and agrees that any legal or equitable action or proceedings arising under or in connection with this Agreement shall be brought exclusively in the federal courts of the United States. By execution and delivery of this Agreement, each party hereto irrevocably submits to and accepts, with respect to any such action or proceeding, generally and unconditionally, the jurisdiction of the aforesaid court, and irrevocably waives any and all rights such party may now or hereafter have to object to such jurisdiction.

 

10.2 Any rights, powers and remedies granted to the Parties by any provisions herein shall not preclude any other rights, powers and remedies available to such Party in accordance with the laws and other provisions under this Agreement, and the exercise of its rights, powers and remedies by a Party shall not preclude its exercise of its other rights, powers and remedies.

 

  3  

 

 

10.3 No failure or delay by a Party to exercise any of its rights, powers and remedies hereunder or in accordance with the laws (hereinafter, the “ Rights ”) shall be construed as a waiver of such Rights, and the waiver of any single or partial Rights shall not preclude its exercise of such Rights in any other way and its exercise of other Rights.

 

10.4 The headings herein contained are for reference only, and in no circumstances shall such headings be used for or affect the interpretation of the provisions hereof.

 

10.5 Each provision contained herein shall be severable from and independent of other provisions, and if at any time one or more provisions herein are held to be invalid, illegal or unenforceable, the validity, legality and enforceability of other provisions herein shall not be affected as a result thereof.

 

10.6 Any amendments or supplements to this Agreement shall be in writing and shall become effective upon due execution by the Parties hereto.

 

10.7 Except for the stipulation of this Agreement, the Borrower shall not assign any of its rights and/or obligations hereunder to any third party without the prior written consent from the Lender, and the Lender is entitled to assign any of its rights and/or obligations hereunder to any of its designated third parties upon notice to the Borrower.

 

10.8 This Agreement shall be binding on the legal successors of the Parties.

 

[THE REMAINDER OF THIS PAGE IS INTENTIONALLY LEFT BLANK]

 

  4  

 

 

(Signature page)

 

IN WITNESS WHEREOF, the Parties have caused this Credit Loan Agreement to be executed as of the date and in the place first set forth above.

 

Lender: Dragon & Tiger Holding Limited.
     
By: /s/ Roy Teng  
Name: Roy Teng  
Title: Director    
     
借款人 Borrower: PBG Water Solutions International Inc.
     
By: /s/ Roy Teng  
Name: Roy Teng  
Title: Director  
     
借款人 Borrower: Yakun International Investment and Holding Group
     
By: /s/ Jin Siming  
Name:    Jin Siming    
Title: Vice President  

 

 

5

 

 

Exhibit 10.4

 

NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.

 

COMMON STOCK PURCHASE WARRANT

 

YAKUN INTERNATIONAL INVESTMENT AND HOLDING GROUP

 

Warrant Shares: 50,000,000 May 1, 2018

 

THIS COMMON STOCK PURCHASE WARRANT (the “ Warrant ”) certifies that, for value received, Dragon & Tiger Holding Limited or assigns (the “ Holder ”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time during the period commencing on June 1, 2019 and ending on or prior to the close of business on the earliest to occur of (x) May 31, 2023, (y) the date upon the Company receives gross proceeds of not less than $20,000,000 from the sale of its equity securities in one or a series of related financings and (z) the last day of the fiscal year following the first fiscal year during which the Company’s annual revenues are $100,000,000 or more (the “ Termination Date ”), but not thereafter, to subscribe for and purchase from Yakun International Investment and Holding Group, a Nevada corporation (the “ Company ”), up to Fifty Million (50,000,000) shares (as subject to adjustment hereunder, the “ Warrant Shares ”) of the Company’s common stock (“ Common Stock ”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

 

Section 1 . Definitions . In addition to the terms defined elsewhere in this Agreement, the following terms have the meanings indicated in this Section 1:

 

Affiliate ” means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.

 

Board of Directors ” means the board of directors of the Company.

 

Business Day ” means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day on which banking institutions in the State of New York are authorized or required by law or other governmental action to close.

  

Commission ” means the United States Securities and Exchange Commission.

 

Exchange Act ” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

 

Liens ” means a lien, charge pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.

 

Person ” means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

 

 

 

 

Proceeding ” means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding, such as a deposition), whether commenced or threatened.

 

Rule 144 ” means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.

 

Securities Act ” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

 

Section 2 . Exercise .

 

a) Exercise of Warrant . Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on or before the Termination Date by delivery to the Company (or such other office or agency of the Company as it may designate by notice in writing to the registered Holder at the address of the Holder appearing on the books of the Company) of a duly executed facsimile copy (or e-mail attachment) of the Notice of Exercise form annexed hereto. Within three (3) Trading Days following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the shares specified in the applicable Notice of Exercise by wire transfer or cashier’s check drawn on a United States. No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise form be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one (1) Business Day of receipt of such notice. The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.

 

b) Exercise Price . The exercise price per share of the Common Stock under this Warrant shall be One Cent ($0.01), subject to adjustment hereunder (the “ Exercise Price ”).

 

c) Mechanics of Exercise .

 

i. Delivery of Warrant Shares Upon Exercise . The Company shall cause the Warrant Shares purchased hereunder to be transmitted by its transfer agent to the Holder by crediting the account of the Holder’s or its designee’s balance account with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (“ DWAC ”) if the Company is then a participant in such system and there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by Holder and otherwise by physical delivery of a certificate, registered in the Company’s share register in the name of the holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is three (3) Trading Days after the delivery to the Company of the Notice of Exercise (such date, the “ Warrant Share Delivery Date ”). Upon delivery of the Notice of Exercise the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares; provided payment of the aggregate Exercise Price is received within three Trading Days of delivery of the Notice of Exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this warrant remains outstanding and exercisable.

 

  2  

 

 

ii. Delivery of New Warrants Upon Exercise . If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects be identical with this Warrant.

 

iii. Rescission Rights . If the Company fails to cause its transfer agent to transmit to the Holder the Warrant Shares pursuant to Section 2(c)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.

 

iv. No Fractional Shares or Scrip . No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise Price or round up to the next whole share.

 

v. Charges, Taxes and Expenses . Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; provided , however , that in the event Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.

 

vi. Closing of Books . The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant, pursuant to the terms hereof.

 

Section 3 . Certain Adjustments .

 

a) Stock Dividends and Splits . If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes a distribution of capital stock in respect of its Common Stock, (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares or (iv) issues by reclassification of shares of the Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or re-classification.

 

  3  

 

 

b) Subsequent Rights Offerings . In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class of shares of Common Stock (the “ Purchase Rights ”), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights.

 

c) Fundamental Transaction . If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company, directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than 50% of the outstanding shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination) (each a “ Fundamental Transaction ”), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the “ Alternate Consideration ”) receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the “ Successor Entity ”) to assume in writing all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with the provisions of this Section 3(e) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Warrant and the other Transaction Documents referring to the “Company” shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations of the Company under this Warrant and the other Transaction Documents with the same.

 

  4  

 

 

d) Calculations . All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.

 

e) Notice to Holder .

 

i.      Adjustment to Exercise Price . Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.

 

ii.      Notice to Allow Exercise by Holder . If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification of the Common Stock, any consolidation or merger to which the Company is a party, any sale or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby the Common Stock is converted into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by facsimile or email to the Holder at its last facsimile number or email address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.

 

Section 4 . Transfer of Warrant .

 

a) Transferability . Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof, this Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.

 

  5  

 

 

b) New Warrants . This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the date hereof and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.

 

c) Warrant Register . The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the “ Warrant Register ”), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.

 

d) Transfer Restrictions . If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public information requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of this Warrant, as the case may be, provides to the Company an opinion of counsel, the form and substance of which opinion shall be reasonably satisfactory to the Company, to the effect that the transfer of this Warrant does not require registration under the Securities Act.

 

e) Representation by the Holder . The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant to sales registered or exempted under the Securities Act.

 

Section 5 . Miscellaneous .

 

a) No Rights as Stockholder Until Exercise . This Warrant does not entitle the Holder to any voting rights, dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set forth in Section 3.

 

b) Loss, Theft, Destruction or Mutilation of Warrant . The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.

 

c) Saturdays, Sundays, Holidays, etc . If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Business Day, then, such action may be taken or such right may be exercised on the next succeeding Business Day.

 

  6  

 

 

d) Authorized Shares .

 

The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of executing stock certificates to execute and issue the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and non-assessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).

 

Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and non-assessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.

 

Before taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.

 

e) Governing Law . All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflict of laws thereof. Each party agrees that all legal proceedings concerning the interpretation, enforcement and defense of this Warrant shall be commenced in the state and federal courts sitting in the City of New York, Borough of Manhattan (the “ New York Courts ”). Each party hereto hereby irrevocably submits to the exclusive jurisdiction of the New York Courts for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of such New York Courts, or such New York Courts are improper or inconvenient venue for such proceeding. Each party hereto hereby irrevocably waives, to the fullest extent permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out of or relating to this Warrant. If any party shall commence an action or proceeding to enforce any provisions of this Warrant, then the prevailing party in such action or proceeding shall be reimbursed by the other party for its attorneys’ fees and other costs and expenses incurred in the investigation, preparation and prosecution of such action or proceeding.

 

f) Restrictions . The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered and the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.

 

  7  

 

 

g) Nonwaiver and Expenses . No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as a waiver of such right or otherwise prejudice the Holder’s rights, powers or remedies, notwithstanding the fact that all rights hereunder terminate on the Termination Date. If the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys’ fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.

 

h) Notices . Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without limitation, any Notice of Exercise, shall be in writing and delivered personally, by facsimile, or sent by a nationally recognized overnight courier service, addressed to the Company, at Yakun International Investment and Holding Group, 1501 Broadway, New York, New York 10036, Attn: Mao Xu, Chief Executive Officer, with a copy to: Mandelbaum Salsburg, P.C., 1270 Avenue of the Americas, Suite 1818, New York, NY 10020, Attn: Vincent J. McGill, Esq., or such other facsimile number, email address or address as the Company may specify for such purposes by notice to the Holders. Any and all notices or other communications or deliveries to be provided by the Company hereunder shall be in writing and delivered personally, by facsimile, or sent by a nationally recognized overnight courier service addressed to each Holder at the facsimile number or address of such Holder appearing on the books of the Company, or if no such facsimile number or address appears on the books of the Company. Any notice or other communication or deliveries hereunder shall be deemed given and effective on the earliest of (i) the date of transmission, if such notice or communication is delivered via facsimile at the facsimile number set forth in this Section prior to 5:30 p.m. (New York City time) on any date, (ii) the next Trading Day after the date of transmission, if such notice or communication is delivered via facsimile at the facsimile number set forth in this Section on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (iii) the second Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service, or (iv) upon actual receipt by the party to whom such notice is required to be given.

  

i) Limitation of Liability . No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the Company.

 

j) Remedies . The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate.

 

k) Successors and Assigns . Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable by the Holder or holder of Warrant Shares.

 

l) Amendment . This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.

 

m) Severability . Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.

 

n) Headings . The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.

 

  8  

 

  

IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.

 

 

YAKUN INTERNATIONAL INVESTMENT

AND HOLDING GROUP

     
  By:

/s/ Mao Xu

    Name: Mao Xu
    Title: CEO

 

  9  

 

 

NOTICE OF EXERCISE

 

To: YAKUN INTERNATIONAL INVESTMENT AND HOLDING GROUP

 

(1)   The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.

 

(2)   Payment has been made in lawful money of the United States.

 

(3)   Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:

 

_______________________________

 

The Warrant Shares shall be delivered to the following DWAC Account Number:

 

_______________________________

 

_______________________________

 

_______________________________

 

[SIGNATURE OF HOLDER]

 

Name of Investing Entity: __________________________

Signature of Authorized Signatory of Investing Entity : ____________________

Name of Authorized Signatory: ____________________________

Title of Authorized Signatory: _____________________________

Date: _______________

 

ASSIGNMENT FORM

 

(To assign the foregoing warrant, execute
this form and supply required information.
Do not use this form to exercise the warrant.)

 

FOR VALUE RECEIVED, _____ shares of Common Stock underlying the foregoing Warrant and all rights evidenced thereby are hereby assigned to _____________.

 

Dated:

 

Holder’s Signature: ______________

 

Holder’s Address: _______________

 

NOTE: The signature to this Assignment Form must correspond with the name as it appears on the face of the Warrant, without alteration or enlargement or any change whatsoever. Officers of corporations and those acting in a fiduciary or other representative capacity should file proper evidence of authority to assign the foregoing Warrant.

 

 

 

 

Exhibit 21.1

 

Subsidiaries

 

Entity   Organized   Percentage Owned  
           
QHY Water Solutions International Corp.   Nevada     100 %
QHY New Zealand LLC.   Nevada     51 %
QHY Oceania S & T Co., Ltd.,   New Zealand     51 %